| SR.NO. | GENERIC NAME | COMPOSITION | ||||
|---|---|---|---|---|---|---|
| 1 | Albendazole Suspension IP | Each 5 ml contains: | ||||
| Albendazole | IP | 200 | mg | |||
| January 1, 1970 | In a Flavoured Syrupy base | q.s | ||||
| Colour: Quinoline Yellow WS | ||||||
| 2 | Albendazole & Ivermectin | Each 5 ml contains: | ||||
| Suspension | Albendazole | IP | 200 | mg | ||
| Ivermectin | IP | 3 | mg | |||
| January 1, 1970 | In a Flavoured Syrupy base | q.s | ||||
| Colour: Erythrosine | ||||||
| 3 | Ambroxol HCl, Guaiphenesin, | Each 5 ml contains: | ||||
| Terbutaline Sulphate Syrup | Ambroxol HCl | IP | 15 | mg | ||
| Guaiphenesin | IP | 50 | mg | |||
| January 1, 1970 | Terbutaline Sulphate | IP | 1.25 | mg | ||
| Flavoured Syrupy base | q.s | |||||
| Colour: Tartrazine | ||||||
| 4 | Ambroxol HCl, Guaiphenesin, | Each 5 ml contains: | ||||
| Phenylephrine HCl & Chlorpheniramine | Ambroxol HCl | IP | 15 | mg | ||
| Maleate syrup | Guaiphenesin | IP | 50 | mg | ||
| Phenylephrine HCl | IP | 5 | mg | |||
| Chlorpheniramine Maleate | IP | 2 | mg | |||
| Flavoured Syrupy base | q.s | |||||
| Colour: Caramel & Ponceau 4R | ||||||
| 5 | Aceclofenac & Paracetamol Suspension | Each 5 ml contains: | ||||
| Aceclofenac | IP | 50 | mg | |||
| Paracetamol | IP | 125 | mg | |||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Sunset Yellow. | ||||||
| 6 | Bromhexine HCl, Terbutaline Sulphate & | Each 5 ml contains: | ||||
| Guaiphenesin Syrup | Bromhexine HCl | IP | 4 | mg | ||
| Terbutaline Sulphate | IP | 1.25 | mg | |||
| Guaiphenesin | IP | 50 | mg | |||
| Flavoured Syrupy base | q.s | |||||
| Colour: Sunset Yellow | ||||||
| 7 | Chlorhexidine Mouthwash IP | Each 5 ml contains: | ||||
| Chlorhexidine Gluconate Solution | IP | |||||
| eq. t oChlorhexidine Gluconate | 0.002 | w/v | ||||
| In Pleasantly Flavoured aqueous base | q.s | |||||
| Colour: Approved Colour | ||||||
| 8 | Chlorhexidine Gluconate, Sodium Fluoride & Zinc Chloride Mouthwash | Each 5 ml contains: | ||||
| Chlorhexidine Gluconate Solution | IP | |||||
| eq. to Chlorhexidine Gluconate | 0.002 | w/v | ||||
| Sodium Fluoride | IP | 0.0005 | w/v | |||
| Zinc Chloride | IP | 0.0009 | w/v | |||
| In Pleasantly Flavoured aqueous base | q.s | |||||
| Colour: Approved Colour | ||||||
| 9 | Disodium Hydrogen Citrate Syrup | Each 5 ml contains: | ||||
| Disodium Hydrogen Citrate | BP | 1.4 | gm | |||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Tartrazine | ||||||
| 10 | Dicyclomine HCl & | Each 1 ml contains: | ||||
| Polydimethylsiloxane Suspension | Dicyclomine HCl | IP | 10 | mg | ||
| Polydimethylsiloxane | IP | 40 | mg | |||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Ponceau 4R | ||||||
| 11 | Levocetirizine Dihydrochloride, | Each 5 ml contains: | ||||
| Phenylephrine HCl & Paracetamol | Levocetirizine Dihydrochloride | IP | 2.5 | mg | ||
| Suspension | Phenylephrine HCl | IP | 5 | mg | ||
| Paracetamol | IP | 125 | mg | |||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Erythrosine | ||||||
| 12 | Levocetirizine Dihydrochloride & | Each 5 ml contains: | ||||
| Montelukast Sodium Suspension | Levocetirizine Dihydrochloride | IP | 2.5 | mg | ||
| Montelukast Sodium | IP | |||||
| eq. to Montelukast | 4 | mg | ||||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Sunset Yellow. | ||||||
| 13 | Mefenamic Acid & Paracetamol | Each 5 ml contains: | ||||
| Suspension | Mefenamic Acid | IP | 50 | mg | ||
| Paracetamol | IP | 125 | mg | |||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Sunset Yellow. | ||||||
| 14 | Megaldrate, Simethicone & | Each 5 ml contains: | ||||
| Oxetacaine Suspension | Megaldrate | IP | 540 | mg | ||
| Simethicone | IP | 50 | mg | |||
| January 1, 1970 | Oxetacaine | BP | 10 | mg | ||
| Sorbital base | q.s | |||||
| Colour: Erythrosine | ||||||
| 15 | Ofloxacin Oral Suspension IP | Each 5 ml contains: | ||||
| Ofloxacin | IP | 50 | mg | |||
| January 1, 1970 | In a Palatable base | q.s | ||||
| Colour: Sunset yellow FCF | ||||||
| 16 | Ondensetron Oral Suspension IP | Each 1 ml contains: | ||||
| Ondensetron HCl | IP | |||||
| eq. to Ondensetron | 2 | mg | ||||
| Flavoured Syrupy base | q.s | |||||
| Colour: Ponceau 4R | ||||||
| 17 | Phenylephrine HCl, | Each 5 ml contains: | ||||
| Chlorpheniramine Maleate Syrup | Phenylephrine HCl | IP | 2.5 | mg | ||
| Chlorpheniramine Maleate | IP | 1 | mg | |||
| January 1, 1970 | In a Flavoured palatable base | q.s | ||||
| Colour: Ponceau 4R | ||||||
| 18 | Paracetamol, Phenylephrine HCl, | Each 5 ml contains: | ||||
| Chlorpheniramine Maleate & Sodium | Paracetamol | IP | 250 | mg | ||
| Citrate Oral Suspension | Phenylephrine HCl | IP | 5 | mg | ||
| Chlorpheniramine Maleate | IP | 2 | mg | |||
| Sodium Citrate | IP | 60 | mg | |||
| In Flavoured mentholated suspension base | ||||||
| Colour: Sunset yellow FCF | ||||||
| 19 | Sucralfate & Oxetacaine Suspension | Each 10 ml contains: | ||||
| Sucralfate | USP | 1 | gm | |||
| Oxetacaine | BP | 20 | mg | |||
| In a Flavoured palatable base | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 20 | Sucralfate Suspension | Each 10 ml contains: | ||||
| Sucralfate | USP | 1 | gm | |||
| In a Flavoured palatable base | q.s | |||||
| Colour: Tartrazine | ||||||
| 21 | Terbutaline Sulphate, Ambroxol HCl & | Each 5 ml contains: | ||||
| Guaiphenesin Cough Expectorants | Terbutaline Sulphate | IP | 1.25 | mg | ||
| Ambroxol HCl | IP | 15 | mg | |||
| Guaiphenesin | IP | 50 | mg | |||
| Flavoured Syrupy base | q.s | |||||
| Colour: Brilliant Blue | ||||||
| 22 | Cyproheptadine & Tricholine Citrate Syrup | Each 5 ml contains: | ||||
| Cyproheptadine Hydrochloride | IP | 2 | mg | |||
| Tricholine Citrate | 275 | mg | ||||
| Flavoured Syrupy base | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 23 | Iron tonic with Vitamin B12 and folic Acid | Each 5 ml contains: | ||||
| Ferric Ammonium Citrate | IP | 80 | mg | |||
| Folic Acid | IP | 0.166 | mg | |||
| January 1, 1970 | Vitamin B12 | IP | 1 | mcg | ||
| Flavoured Syrupy base | q.s | |||||
| Colour: Caramel | ||||||
| 24 | Iron, folic Acid,Vitamin B12 & Vitamin B6 Oral Drops | Each 5 ml contains: | ||||
| Ferric Ammonium Citrate | IP | 150 | mg | |||
| (eq. to Elemental Iron 30 mg) | ||||||
| Folic Acid | IP | 0.2 | mg | |||
| January 1, 1970 | Vitamin B12 | IP | 5 | mcg | ||
| Vitamin B6 | IP | 1 | mg | |||
| Flavoured palatable base | q.s | |||||
| Colour: Carmosine | ||||||
| 25 | Multi Vitamin And Multi Mineral Syrup | Each 5 ml contains: | ||||
| Protein Hydrolysate 20% | 0.333 | gm | ||||
| Prridoxine Hcl | IP | 0.5 | mg | |||
| Niacinamide | IP | 15 | mg | |||
| Iron Choline citrate | 15 | mcg | ||||
| Magnisium Chloride | IP | 3.33 | mg | |||
| Manganese Chloride | USP | 0.03 | mg | |||
| Zinc Sulphate | IP | 44 | mg | |||
| eq. to elemental Zinc | ||||||
| L-Lysine Hydrochloride | USP | 20 | mg | |||
| Flavoured syrupy base | q.s | |||||
| Colour: Caramal | ||||||
| 26 | Roxythromycin Suspension | Each 5 ml contains: | ||||
| Roxythromycin | IP | 50 | mg | |||
| January 1, 1970 | Flavoured Syrupy base | q.s | ||||
| Colour: Sunset Yellow FCF | ||||||
| 27 | Azithromycin Oral Suspension IP | Each 5 ml contains: | ||||
| Azithromycin Dihydrate | IP | |||||
| Eq. to Azithromycin | 200 | mg | ||||
| January 1, 1970 | Flavoured Syrupy base | q.s | ||||
| Colour: Quinoline Yellow WS | ||||||
| 28 | Azithromycin Oral Suspension IP | Each 5 ml contains: | ||||
| Azithromycin Dihydrate | IP | |||||
| Eq. to Azithromycin | 100 | mg | ||||
| January 1, 1970 | Flavoured Syrupy base | q.s | ||||
| Colour: Tartrazine | ||||||
| 29 | Albendazole Tablets IP | Each uncoated chewable tablet contains: | ||||
| Albendazole | IP | 400 | mg | |||
| Excipients | q.s | |||||
| Colour: Sunset Yellow | ||||||
| 30 | Albendazole & Ivermectin Tablets | Each uncoated chewable tablet contains: | ||||
| Albendazole | IP | 400 | mg | |||
| Ivermectin | IP | 6 | mg | |||
| Excipients | q.s | |||||
| Colour: Sunset Yellow | ||||||
| 31 | Allopurinol Tablets IP | Each uncoated tablet contains: | ||||
| Allopurinol | IP | 100 | mg | |||
| Excipients | q.s | |||||
| 32 | Allopurinol Tablets IP | Each uncoated tablet contains: | ||||
| Allopurinol | IP | 300 | mg | |||
| Excipients | q.s | |||||
| 33 | Atenolol Tablets IP | Each film coated tablet contains: | ||||
| Atenolol | IP | 50 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Sunset Yellow & Titanium Dioxide IP | ||||||
| 34 | Aceclofenac & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Aceclofenac | IP | 100 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| Colour: Erythrosine | ||||||
| 35 | Aceclofenac & Paracetamol Tablets | Each film coated tablet contains: | ||||
| Aceclofenac | IP | 100 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Yellow Oxide of Iron | ||||||
| 36 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each uncoated tablet contains: | ||||
| Aceclofenac | IP | 100 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Chlorzoxazone | USP | 250 | mg | |||
| Excipients | q.s | |||||
| 37 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each filmcoated tablet contains: | ||||
| Aceclofenac | IP | 100 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Chlorzoxazone | USP | 250 | mg | |||
| Excipients | q.s | |||||
| Colours: Sunset Yellow FCF | ||||||
| 38 | Artemether & Lumefantrine Tablets | Each uncoated tablet contains: | ||||
| Artemether | IP | 80 | mg | |||
| January 1, 1970 | Lumefantrine | 480 | mg | |||
| Excipients | q.s | |||||
| Colour: Tartrazine | ||||||
| 39 | Aceclofenac & Paracetamol Tablets | Each film coated tablet contains: | ||||
| Aceclofenac | IP | 100 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
| 40 | Chlorpheniramine Maleate Tablets IP | Each uncoated tablet contains: | ||||
| Chlorpheniramine Maleate | IP | 4 | mg | |||
| Excipients | q.s | |||||
| 41 | Clopidogrel Tablets IP | Each film coated tablet contains: | ||||
| Clopidogrel | IP | 75 | mg | |||
| Excipients | q.s. | |||||
| Colours: Tartrazine & Titanium Dioxide IP | ||||||
| 42 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Ciprofloxacin Hydrochloride | IP | |||||
| January 1, 1970 | Eq. to Ciprofloxacin | 250 | mg | |||
| Excipients | q.s | |||||
| Colour: Quinoline Yellow Lake & Titanium Dioxide IP | ||||||
| 43 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Ciprofloxacin Hydrochloride | IP | |||||
| January 1, 1970 | Eq. to Ciprofloxacin | 250 | mg | |||
| Excipients | q.s | |||||
| Colour: Titanium Dioxide IP | ||||||
| 44 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Ciprofloxacin Hydrochloride | IP | |||||
| January 1, 1970 | Eq. to Ciprofloxacin | 250 | mg | |||
| Excipients | q.s | |||||
| Colour: Titanium Dioxide IP & Red Oxide Of Iron | ||||||
| 45 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Ciprofloxacin Hydrochloride | IP | |||||
| January 1, 1970 | Eq. to Ciprofloxacin | 500 | mg | |||
| Excipients | q.s | |||||
| Colour: Titanium Dioxide IP | ||||||
| 46 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Ciprofloxacin Hydrochloride | IP | |||||
| January 1, 1970 | Eq. to Ciprofloxacin | 500 | mg | |||
| Excipients | q.s | |||||
| Colour: Quinoline Yellow | ||||||
| 47 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Ciprofloxacin Hydrochloride | IP | |||||
| Eq. to Ciprofloxacin | 500 | mg | ||||
| Excipients | q.s | |||||
| Colour: Titanium Dioxide IP & Red Oxide Of Iron | ||||||
| 48 | Ciprofloxacin & Tinidazole Tablets | Each film coated tablet contains: | ||||
| Ciprofloxacin Hydrochloride | IP | |||||
| Eq. to Ciprofloxacin | 500 | mg | ||||
| Tinidazole | IP | 600 | mg | |||
| Excipients | q.s | |||||
| Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
| 49 | Clotrimazole & Tinidazole Vaginal Tablets | Each uncoated vaginal tablet contains: | ||||
| Clotrimazole | IP | 200 | mg | |||
| January 1, 1970 | Tinidazole | IP | 600 | mg | ||
| Excipients | q.s | |||||
| 50 | Clotrimazole, Tinidazole & Povidone Iodine Vaginal Tablets | Each uncoated vaginal tablet contains: | ||||
| Clotrimazole | IP | 200 | mg | |||
| January 1, 1970 | Tinidazole | IP | 600 | mg | ||
| Povidone Iodine | IP | 200 | mg | |||
| Excipients | q.s | |||||
| 51 | Cyproheptadine Hydrochloride Tablets IP | Each uncoated tablet contains: | ||||
| Cyproheptadine Hydrochloride | IP | 4 | mg | |||
| Excipients | q.s | |||||
| 52 | Diclofenac Sodium Tablets IP | Each enteric coated tablet contains: | ||||
| Diclofenac Sodium | IP | 50 | mg | |||
| Excipients | q.s | |||||
| Colour: Sunset yellow & Titanium Dioxide IP | ||||||
| 53 | Diclofenac Prolonged-release Tablets IP | Each film coated prolonged-Release tablet contains: | ||||
| Diclofenac Sodium | IP | 100 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
| 54 | Diclofenac Sodium & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Diclofenac Sodium | IP | 50 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| Colours: Brilliant Blue | ||||||
| 55 | Diclofenac Sodium, Paracetamol & Chlorzoxazone Tablets | Each uncoated tablet contains: | ||||
| Diclofenac Sodium | IP | 50 | mg | |||
| January 1, 1970 | Paracetamol | IP | 325 | mg | ||
| Chlorzoxazone | USP | 250 | mg | |||
| Excipients | q.s | |||||
| Colours:Quinoline Yellow | ||||||
| 57 | Drotaverine & Mefenamic Acid Tablets | Each filmcoated tablet contains: | ||||
| Drotaverine Hydrochloride | IP | |||||
| Eq. to Drotaverine | 40 | mg | ||||
| Mefenamic Acid | IP | 250 | mg | |||
| Excipients | q.s. | |||||
| Colours: Sunset Yellow & Titanium Dioxide IP | ||||||
| 58 | Deflazacort Tablets | Each film coated tablet contains: | ||||
| Deflazacort | 6 | mg | ||||
| Excipients | q.s. | |||||
| Colours: Tartrazine & Titanium Dioxide IP | ||||||
| 59 | Deflazacort Tablets | Each film coated tablet contains: | ||||
| Deflazacort | 30 | mg | ||||
| Excipients | q.s. | |||||
| Colours: Tartrazine & Titanium Dioxide IP | ||||||
| 60 | Dicyclomine Hydrochloride & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Dicyclomine Hydrochloride | IP | 20 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| 61 | Dicyclomine Hydrochloride & Mefenamic Acid Tablets | Each uncoated tablet contains: | ||||
| Dicyclomine Hydrochloride | IP | 10 | mg | |||
| Mefenamic Acid | IP | 250 | mg | |||
| Excipients | q.s | |||||
| Colour: Tartrazine | ||||||
| 62 | Etoricoxib Tablets IP | Each film coated tablet contains: | ||||
| Etoricoxib | IP | 60 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Brilliant Blue, Tartrazine & Titanium Dioxide IP | ||||||
| 63 | Etoricoxib Tablets IP | Each film coated tablet contains: | ||||
| Etoricoxib | IP | 90 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Brilliant Blue, Tartrazine & Titanium Dioxide IP | ||||||
| 64 | Etoricoxib Tablets IP | Each film coated tablet contains: | ||||
| Etoricoxib | IP | 120 | mg | |||
| Excipients | q.s | |||||
| Colours: Brilliant Blue, Tartrazine & Titanium Dioxide IP | ||||||
| 65 | Etoricoxib & Paracetamol Tablets | Each film coated tablet contains: | ||||
| Etoricoxib | IP | 60 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| Colours: Brilliant Blue, Tartrazine & Titanium Dioxide IP | ||||||
| 66 | Etamsylate Tablets | Each uncoated tablet contains: | ||||
| January 1, 1970 | Etamsylate | BP | 500 | mg | ||
| Excipients | q.s | |||||
| 67 | Ethambutol Hydrochloride Tablets IP | Each film coated tablet contains: | ||||
| Ethambutol Hydrochloride | IP | 800 | mg | |||
| Excipients | q.s | |||||
| Colour: Titanium Dioxide IP | ||||||
| 68 | Fluconazole Tablets IP | Each uncoated tablet contains: | ||||
| Fluconazole | IP | 150 | mg | |||
| Excipients | q.s | |||||
| Colours: Ponceau 4R | ||||||
| 69 | Fexofenadine Hydrochloride & Montelukast Tablets | Each film coated tablet contains: | ||||
| Fexofenadine Hydrochloride | IP | 120 | mg | |||
| Montelukast Sodium | IP | |||||
| Eq. to Montelukast | 10 | mg | ||||
| Excipients | q.s. | |||||
| Colours: Tartrazine & Titanium Dioxide IP | ||||||
| 70 | Famotidine Tablets IP | Each film coated tablet contains: | ||||
| Famotidine | IP | 20 | mg | |||
| Excipients | q.s | |||||
| Colour: Brilliant Blue FCF | ||||||
| 71 | Gliclazide & Metformin Hydrochloride Tablets | Each uncoated tablet contains: | ||||
| Gliclazide | IP | 80 | mg | |||
| Metformin Hydrochloride | IP | 500 | mg | |||
| Excipients | q.s | |||||
| 72 | Glimipride & Metformin Tablets | Each uncoated tablet contains: | ||||
| Glimipride | IP | 2 | mg | |||
| Metformin Hydrochloride | IP | 500 | mg | |||
| Excipients | q.s. | |||||
| 73 | Ibuprofen & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Ibuprofen | IP | 400 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| 74 | Lornoxichem & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Lornoxichem | IP | 8 | mg | |||
| January 1, 1970 | Paracetamol | IP | 325 | mg | ||
| Excipients | q.s | |||||
| 75 | Linezolid Tablets IP | Each filmcoated tablet contains: | ||||
| January 1, 1970 | Linezolid | IP | 600 | mg | ||
| Excipients | q.s | |||||
| Colours: Tartrazine & Titanium Dioxide IP | ||||||
| 76 | Loratidine Tablets BP | Each filmcoated tablet contains: | ||||
| Loratidine | BP | 10 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Erythrosine | ||||||
| 77 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Levofloxacin Hemihydrate | IP | |||||
| Eq. to Levofloxacin | 750 | mg | ||||
| Excipients | q.s | |||||
| Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
| 78 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Levofloxacin Hemihydrate | IP | |||||
| Eq. to Levofloxacin | 750 | mg | ||||
| Excipients | q.s | |||||
| Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
| 79 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Levofloxacin Hemihydrate | IP | |||||
| Eq. to Levofloxacin | 750 | mg | ||||
| Excipients | q.s | |||||
| Colours: Titanium Dioxide IP | ||||||
| 80 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Levofloxacin Hemihydrate | IP | |||||
| Eq. to Levofloxacin | 500 | mg | ||||
| Excipients | q.s | |||||
| Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
| 81 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Levofloxacin Hemihydrate | IP | |||||
| January 1, 1970 | Eq. to Levofloxacin | 500 | mg | |||
| Excipients | q.s | |||||
| Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
| 82 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Levofloxacin Hemihydrate | IP | |||||
| Eq. to Levofloxacin | 250 | mg | ||||
| Excipients | q.s | |||||
| Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
| 83 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Levofloxacin Hemihydrate | IP | |||||
| January 1, 1970 | Eq. to Levofloxacin | 250 | mg | |||
| Excipients | q.s | |||||
| Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
| 84 | Levofloxacin & Ornidazole Tablets | Each film coated tablet contains: | ||||
| Levofloxacin Hemihydrate | IP | |||||
| January 1, 1970 | Eq. to Levofloxacin | 250 | mg | |||
| Ornidazole | IP | 500 | mg | |||
| Excipients | q.s | |||||
| Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
| 85 | Levocetirizine Dihydrochloride Tablets IP | Each Film coated tablet contains: | ||||
| Levocetirizine Di Hydrochloride | IP | 5 | mg | |||
| Excipients | q.s | |||||
| Colour: Titanium Dioxide IP | ||||||
| 86 | Levocetirizine Dihydrochloride Tablets IP | Each Film coated tablet contains: | ||||
| Levocetirizine Di Hydrochloride | IP | 10 | mg | |||
| Excipients | q.s | |||||
| Colour: Quinoline Yellow & Titanium Dioxide IP | ||||||
| 87 | Levocetirizine Di HCl & Ambroxol HCl Tablets | Each film coated tablet contains: | ||||
| Levocetirizine Di Hydrochloride | IP | 5 | mg | |||
| January 1, 1970 | Ambroxol Hydrochloride | IP | 60 | mg | ||
| Excipients | q.s | |||||
| Colour: Titanium Dioxide IP | ||||||
| 88 | Loperamide HCl Tablets IP | Each uncoated tablet contains: | ||||
| Loperamide Hydrochloride | IP | 2 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Brilliant Blue & Titanium Dioxide IP | ||||||
| 89 | Montelukast Sodium & Levocetirizine HCl Tablets | Each film coated tablet contains: | ||||
| Montelukast Sodium | IP | |||||
| Eq. to Montelukast | 10 | mg | ||||
| January 1, 1970 | Levocetirizine Di Hydrochloride | IP | 5 | mg | ||
| Excipients | q.s | |||||
| Colours: Quinoline Yellow & Titanium Dioxide IP | ||||||
| 90 | Montelukast Sodium, Ambroxol & Levocetirizine HCl Tablets | Each film coated tablet contains: | ||||
| Montelukast Sodium | IP | |||||
| Eq. to Montelukast | 10 | mg | ||||
| Levocetirizine Di Hydrochloride | IP | 5 | mg | |||
| January 1, 1970 | Ambroxol Hydrochloride | IP | 15 | mg | ||
| Excipients | q.s | |||||
| Colours: Tartrazine & Titanium Dioxide IP | ||||||
| 91 | Mefenamic Acid Tablets BP | Each uncoated tablet contains: | ||||
| Mefenamic Acid | IP | 500 | mg | |||
| Excipients | q.s | |||||
| 92 | Mefenamic Acid & Tranexamic Acid Tablets | Each film coated tablet contains: | ||||
| Mefenamic Acid | IP | 250 | mg | |||
| Tranexamic Acid | USP | 500 | mg | |||
| Excipients | q.s. | |||||
| Colours: Sunset Yellow & Titanium Dioxide IP | ||||||
| 93 | Metoclopramide HCl Tablets IP | Each uncoated tablet contains: | ||||
| Metoclopramide HCl | IP | |||||
| Eq. to anhydrous Metoclopramide HCl | 10 | mg | ||||
| Excipients | q.s | |||||
| 94 | Metoclopramide HCl & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Metoclopramide HCl | IP | |||||
| Eq. to anhydrous Metoclopramide HCl | 5 | mg | ||||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| 95 | Mefenamic Acid Tablets BP | Each uncoated tablet contains: | ||||
| January 1, 1970 | Mefenamic Acid | IP | 250 | mg | ||
| Excipients | q.s | |||||
| 96 | Norfloxacin Tablets IP | Each film coated tablet contains: | ||||
| Norfloxacin | IP | 400 | mg | |||
| Excipients | q.s | |||||
| Colours: Tartrazine & Titanium Dioxide IP | ||||||
| 97 | Norfloxacin & Tinidazole Tablets | Each film coated tablet contains: | ||||
| Norfloxacin | IP | 400 | mg | |||
| Tinidazole | IP | 600 | mg | |||
| Excipients | q.s | |||||
| Colours: Tartrazine & Titanium Dioxide IP | ||||||
| 98 | Nimesulide Tablets | Each uncoated tablet contains: | ||||
| January 1, 1970 | Nimesulide | BP | 100 | mg | ||
| Excipients | q.s | |||||
| 99 | Nimesulide & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Nimesulide | BP | 100 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 100 | Nimesulide, Paracetamol & Chlorzoxazone Tablets | Each uncoated tablet contains: | ||||
| Nimesulide | BP | 100 | mg | |||
| January 1, 1970 | Paracetamol | IP | 325 | mg | ||
| Chorzoxazone | USP | 375 | mg | |||
| Excipients | q.s | |||||
| Colour:Quinoline Yellow WS | ||||||
| 101 | Ofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Ofloxacin | IP | 400 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colour: Quinoline Yellow | ||||||
| 102 | Ofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Ofloxacin | IP | 200 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colour: Titanium Dioxide IP | ||||||
| 104 | Ofloxacin Tablets IP | Each film coated tablet contains: | ||||
| Ofloxacin | IP | 200 | mg | |||
| Excipients | q.s | |||||
| Colour: Quinoline Yellow | ||||||
| 105 | Ofloxacin Dispersible Tablets | Each uncoatd dispersible tablet contains: | ||||
| Ofloxacin | IP | 100 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colour: Red Oxide of Iron | ||||||
| 106 | Ofloxacin & Tinidazole Tablets | Each filmcoated tablet contains: | ||||
| Ofloxacin | IP | 200 | mg | |||
| January 1, 1970 | Tinidazole | IP | 600 | mg | ||
| Excipients | q.s | |||||
| Colours: Quinoline Yellow & Titanium Dioxide IP | ||||||
| 107 | Ornidazole Tablets IP | Each film coated tablet contains: | ||||
| Ornidazole | IP | 500 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colour: Titanium Dioxide IP | ||||||
| 108 | Ondansetron Orally Disintegrating Tablets IP | Each uncoated Orally Disintegrating tablet contains: | ||||
| Ondansetron Hydrochloride | IP | |||||
| January 1, 1970 | Eq. to Ondansetron | 4 | mg | |||
| Excipients | q.s | |||||
| 109 | Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 500 | mg | |||
| Excipients | q.s | |||||
| 110 | Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 650 | mg | |||
| Excipients | q.s | |||||
| 111 | Paracetamol & Caffeine Tablets | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 500 | mg | |||
| January 1, 1970 | Caffeine | IP | 30 | mg | ||
| Excipients | q.s | |||||
| Colour: Red Oxide of Iron | ||||||
| 112 | Paracetamol, Phenylepherine HCl , Chlorpheniramine Maleate & Caffeine Tablets | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 325 | mg | |||
| Phenylepherine Hydrochloride | IP | 5 | mg | |||
| January 1, 1970 | Chlorpheniramine Maleate | IP | 2 | mg | ||
| Caffeine (anhydrous) | IP | 30 | mg | |||
| Excipients | q.s | |||||
| Colour: Quinoline Yellow WS | ||||||
| 113 | Paracetamol, Phenylepherine HCl & Cetirizine HCl Tablets | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 325 | mg | |||
| January 1, 1970 | Phenylepherine Hydrochloride | IP | 5 | mg | ||
| Cetirizine Hydrochloride | IP | 5 | mg | |||
| Excipients | q.s | |||||
| 114 | Paracetamol, Phenylepherine HCl & Cetirizine HCl Tablets | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 325 | mg | |||
| January 1, 1970 | Phenylepherine Hydrochloride | IP | 5 | mg | ||
| Cetirizine Hydrochloride | IP | 5 | mg | |||
| Excipients | q.s | |||||
| Colour: Quinoline Yellow WS | ||||||
| 115 | Paracetamol, Phenylepherine HCl , Chlorpheniramine Maleate, Guaiphenesin & Bromhexine HCl Tablets | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 325 | mg | |||
| Phenylepherine Hydrochloride | IP | 10 | mg | |||
| January 1, 1970 | Chlorpheniramine Maleate | IP | 2 | mg | ||
| Guaiphenesin | IP | 100 | mg | |||
| Bromhexine HCl | IP | 8 | mg | |||
| Excipients | q.s | |||||
| Colour: Tartrazine | ||||||
| 116 | Pheniramine Maleate Tablets IP | Each uncoated tablet contains: | ||||
| January 1, 1970 | Pheniramine Maleate | IP | 25 | mg | ||
| Excipients | q.s | |||||
| 117 | Pantoprazole Gastro-resistant Tablets IP | Each enteric coated tablet contains: | ||||
| Pantoparazole Sodium Sesquihydrate | IP | |||||
| January 1, 1970 | Eq. to Pantoprazole | 40 | mg | |||
| Excipients | q.s | |||||
| Colours: Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
| 118 | Pantoprazole Sodium & Domperidone Tablets | Each enteric coated tablet contains: | ||||
| Pantoparazole Sodium Sesquihydrate | IP | |||||
| Eq. to Pantoprazole | 20 | mg | ||||
| Domperidone | IP | 10 | mg | |||
| Excipients | q.s | |||||
| Colour: Tartrazine | ||||||
| 119 | Pantoprazole Sodium & Domperidone Tablets | Each enteric coated tablet contains: | ||||
| Pantoparazole Sodium Sesquihydrate | IP | |||||
| Eq. to Pantoprazole | 40 | mg | ||||
| Domperidone | IP | 10 | mg | |||
| Excipients | q.s | |||||
| Colour: Tartrazine | ||||||
| 120 | Pantoprazole Sodium & Domperidone Tablets | Each enteric coated tablet contains: | ||||
| Pantoparazole Sodium Sesquihydrate | IP | |||||
| January 1, 1970 | Eq. to Pantoprazole | 40 | mg | |||
| Domperidone | IP | 10 | mg | |||
| Excipients | q.s | |||||
| Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
| 121 | Piroxicam Dispersible Tablets | Each uncoated dispersible tablet contains: | ||||
| Piroxicam | IP | 20 | mg | |||
| Excipients | q.s | |||||
| 122 | Pyrazinamide Tablets IP | Each uncoated tablet contains: | ||||
| Pyrazinamide | IP | 750 | mg | |||
| Excipients | q.s. | |||||
| 123 | Prochloperazine Maleate Tablets IP | Each uncoated mouth Dissolving tablet contains: | ||||
| Prochloperazine Maleate | IP | 5 | mg | |||
| Excipients | q.s | |||||
| 124 | Prochlorperazine Maleate & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Prochlorperazine Maleate | IP | 5 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| 125 | Ranitidine Tablets IP | Each film coated tablet contains: | ||||
| Ranitidine Hydrochloride | IP | |||||
| January 1, 1970 | Eq. to Ranitidine | 150 | mg | |||
| Excipients | q.s | |||||
| Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
| 126 | Ranitidine Tablets IP | Each film coated tablet contains: | ||||
| Ranitidine Hydrochloride | IP | |||||
| January 1, 1970 | Eq. to Ranitidine | 150 | mg | |||
| Excipients | q.s | |||||
| Colours: Brilliant Blue , Tartrazine & Titanium Dioxide IP | ||||||
| 127 | Ranitidine & Domperidone Tablets | Each film coated tablet contains: | ||||
| Ranitidine Hydrochloride | IP | |||||
| Eq. to Ranitidine | 150 | mg | ||||
| January 1, 1970 | Domperidone | IP | 10 | mg | ||
| Excipients | q.s | |||||
| Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
| 128 | Rabeprazole Gastro-resistant Tablets IP | Each enteric coated tablet contains: | ||||
| Rabeprazole Sodium | IP | 20 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
| 129 | Rabeprazole Sodium & Domperidone Tablets | Each enteric coated tablet contains: | ||||
| Rabeprazole Sodium | IP | 20 | mg | |||
| Domperidone | IP | 10 | mg | |||
| Excipients | q.s | |||||
| Colours: Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
| 130 | Roxithromycin & Ambroxol Tablets | Each film coated tablet contains: | ||||
| Roxithromycin | IP | 150 | mg | |||
| Ambroxol Hydroxide | IP | 30 | mg | |||
| Excipients | q.s. | |||||
| Colours: Brilliant Blue & Titanium Dioxide IP | ||||||
| 131 | Rifampicin & Isoniazid Tablets IP | Each film coated tablet contains: | ||||
| Rifampicin | IP | 450 | mg | |||
| January 1, 1970 | Isoniazid | IP | 300 | mg | ||
| Excipients | q.s | |||||
| Colours: Red Oxide of Iron | ||||||
| 132 | Tinidazole Tablets IP | Each film coated tablet contains: | ||||
| Tinidazole | IP | 500 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Quninoline Yellow, Yellow Oxide of iron & Titanium Dioxide IP | ||||||
| 133 | Triprolidine HCl & Phenylphrine HCl Tablets | Each uncoated tablet contains: | ||||
| Triprolidine Hydrochloride | IP | 2.5 | mg | |||
| January 1, 1970 | Phenylphrine Hydrochloride | IP | 5 | mg | ||
| Excipients | q.s | |||||
| 134 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: | ||||
| Ursodeoxycholic Acid | IP | 300 | mg | |||
| Excipients | q.s. | |||||
| Colours: Sunset Yellow & Titanium Dioxide IP | ||||||
| 135 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: | ||||
| Ursodeoxycholic Acid | IP | 150 | mg | |||
| Excipients | q.s. | |||||
| Colours: Sunset Yellow & Titanium Dioxide IP | ||||||
| 136 | Cetirizine Hydrochloride Tablets IP | Each film coated tablet contains: | ||||
| Cetirizine Hydrochloride | IP | 10 | mg | |||
| Excipients | q.s | |||||
| Colour: Titanium Dioxide IP | ||||||
| 137 | Amoxycillin Dispersible Tablets IP | Each uncoated Dispersible tablet contains: | ||||
| Amoxycillin Trihydrate | IP | |||||
| eq. to Amoxycillin | 125 | mg | ||||
| Excipients | q.s. | |||||
| 138 | Amoxycillin Dispersible Tablets IP | Each uncoated Dispersible tablet contains: | ||||
| Amoxycillin Trihydrate | IP | |||||
| January 1, 1970 | eq. to Amoxycillin | 250 | mg | |||
| Excipients | q.s. | |||||
| 139 | Azithromycin Tablets IP 250 mg | Each film coated tablet contains: | ||||
| Azithromycin dihydrate | IP | |||||
| eq. to Anhydrous Azithromycin | 250 | mg | ||||
| Excipients | q.s. | |||||
| Colour: Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
| 140 | Azithromycin Tablets IP 500 mg | Each film coated tablet contains: | ||||
| Azithromycin dihydrate | IP | |||||
| eq. to Anhydrous Azithromycin | 500 | mg | ||||
| Excipients | q.s. | |||||
| Colour: Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
| 141 | Aceclofenac, Paracetamol | Each film coated tablet contains: | ||||
| & Serratiopeptidase tablets | Aceclofenac | IP | 100 | mg | ||
| Paracetamol | IP | 325 | mg | |||
| Serratiopeptidase (30,000 units of Serratiopeptidase as enteric coated granules) | IP | 15 | mg | |||
| Excipients | q.s. | |||||
| Colour: Tartrazine & Titanium Dioxide IP | ||||||
| 142 | Betamethasone Sodium Phosphate | Each uncoated tablet contains: | ||||
| Tablets IP | Betamethasone Sodium Phosphate | IP | ||||
| eq. to Betamethasone | 0.5 | mg | ||||
| January 1, 1970 | Excipients | q.s. | ||||
| Colour: Erythrosine | ||||||
| 143 | Cefixime Dispersible Tablets | Each uncoated dispersible tablet contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Anhydrous Cefixime | 100 | mg | ||||
| Excipients | q.s. | |||||
| 144 | Cefixime Dispersible Tablets | Each Uncoated Dispersible tablet contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Cefixime (Anhydrous) | 200 | mg | ||||
| Excipients | q.s. | |||||
| 145 | Cefixime Trihydrate Tablets IP | Each film coated tablet contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Anhydrous Cefixime | 200 | mg | ||||
| Excipients | q.s. | |||||
| Colour: Titanium Dioxide IP | ||||||
| 146 | Cefixime Tablets IP | Each film coated tablet contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Anhydrous Cefixime | 400 | mg | ||||
| Excipients | q.s. | |||||
| Colour: Titanium Dioxide IP | ||||||
| 147 | Cefixime & Ofloxacin tablets | Each film coated tablet contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Anhydrous Cefixime | 200 | mg | ||||
| January 1, 1970 | Ofloxacin | IP | 200 | mg | ||
| Excipients | q.s. | |||||
| Colour: Quinoline Yellow & Titanium Dioxide IP | ||||||
| 148 | Cefpodoxime Proxetil Dispersible | Each uncoated dispersible tablet contains: | ||||
| Tablets | Cefpodoxime Proxetil | IP | ||||
| eq. to Cefpodoxime | 100 | mg | ||||
| Excipients | q.s. | |||||
| 149 | Cefpodoxime Proxetil Dispersible | Each uncoated dispersible tablet contains: | ||||
| Tablets | Cefpodoxime Proxetil | IP | ||||
| eq. to Cefpodoxime | 200 | mg | ||||
| Excipients | q.s. | |||||
| 150 | Cefpodoxime & Ofloxacin tablets | Each film coated tablet contains: | ||||
| Cefpodoxime Proxetil | IP | |||||
| eq. to Cefpodoxime | 200 | mg | ||||
| Ofloxacin | IP | 200 | mg | |||
| Excipients | q.s. | |||||
| Colour: Tartrazine & Titanium Dioxide IP | ||||||
| 151 | Cefuroxime Axetil Tablet IP | Each film coated tablet contains: | ||||
| Cefuroxime Axetil | IP | |||||
| eq. to Cefuroxime | 250 | mg | ||||
| Excipients | q.s. | |||||
| Colour: Titanium Dioxide IP | ||||||
| 152 | Cefuroxime Axetil Tablet IP | Each film coated tablet contains: | ||||
| Cefuroxime Axetil | IP | |||||
| January 1, 1970 | eq. to Cefuroxime | 500 | mg | |||
| Excipients | q.s. | |||||
| Colour: Titanium Dioxide IP | ||||||
| 153 | Cefuroxime Axetil & Linzolid Tablet | Each film coated tablet contains: | ||||
| Cefuroxime Axetil | IP | |||||
| eq. to Cefuroxime | 500 | mg | ||||
| January 1, 1970 | Linzolid | IP | 600 | mg | ||
| Excipients | q.s. | |||||
| 154 | Diclofenac Potassium & | Each film coated tablet contains: | ||||
| Serratiopeptidase tablets | Diclofenac Potassium | BP | 50 | mg | ||
| January 1, 1970 | Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | ||
| Excipients | q.s. | |||||
| Colour: Titanium Dioxide IP | ||||||
| 155 | Diclofenac Sodium & | Each film coated tablet contains: | ||||
| Serratiopeptidase tablets | Diclofenac Sodium | IP | 50 | mg | ||
| January 1, 1970 | Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | ||
| Excipients | q.s. | |||||
| Colour: Sunset Yellow & Titanium Dioxide IP | ||||||
| 156 | Folic Acid Tablets IP | Each uncoated tablet contains: | ||||
| January 1, 1970 | Folic Acid | IP | 5 | mg | ||
| Excipients | q.s. | |||||
| 157 | Levonorgestrel Tablets IP | Each film coated tablet contains: | ||||
| Levonorgestrel | IP | 1.5 | mg | |||
| January 1, 1970 | Excipients | q.s. | ||||
| Colour: Erythrosine & Titanium Dioxide IP | ||||||
| 158 | Methylergometrine Maleate Tablets IP | Each film coated tablet contains: | ||||
| Methylergometrine Maleate | IP | 0.125 | mg | |||
| January 1, 1970 | Excipients | q.s. | ||||
| Colour: Titanium Dioxide IP | ||||||
| 159 | Norethisterone Tablets IP | Each uncoated tablet contains: | ||||
| Norethisterone | IP | 5 | mg | |||
| Excipients | q.s. | |||||
| 160 | Paracetamol, Diclofenac Sodium | Each film coated tablet contains: | ||||
| & Serratiopeptidase tablets | Paracetamol | IP | 325 | mg | ||
| Diclofenac Sodium | IP | 50 | mg | |||
| January 1, 1970 | Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | ||
| Excipients | q.s. | |||||
| Colour: Tartrazine | ||||||
| 161 | Paracetamol, Diclofenac Potassium | Each film coated tablet contains: | ||||
| & Serratiopeptidase tablets | Paracetamol | IP | 325 | mg | ||
| Diclofenac Potassium | BP | 50 | mg | |||
| January 1, 1970 | Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | ||
| Excipients | q.s. | |||||
| Colour: Sunset Yellow & Titanium Dioxide IP | ||||||
| 162 | Roxithromycin Tablets IP | Each uncoated dispersible tablet contains: | ||||
| Roxithromycin | IP | 50 | mg | |||
| January 1, 1970 | Excipients | q.s. | ||||
| Colour:Sunset yellow FCF | ||||||
| 163 | Roxithromycin Tablets IP | Each film coated tablet contains: | ||||
| Roxithromycin | IP | 150 | mg | |||
| January 1, 1970 | Excipients | q.s. | ||||
| Colour: Brilliant Blue FCF | ||||||
| 164 | Gabapentin Capsule IP | Each hard gelatin capsule contains: | ||||
| Gabatentin | IP | 300 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Approved colour used in empty capsule shells | ||||||
| 165 | Loperamide Capsule IP | Each hard gelatin capsule contains: | ||||
| Loperamide Hydrochloride | IP | 2 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Approved colour used in empty capsule shells | ||||||
| 166 | Pantoprazole & Domperidone SR Capsules | Each hard gelatin capsule contains: | ||||
| Pantoparazole Sodium Sesquihydrate | IP | |||||
| Eq. to Pantoprazole | 40 | mg | ||||
| (As enteric coated Pellets) | ||||||
| Domperidone | IP | 30 | mg | |||
| (As Sustained release Pellets) | ||||||
| Colour: Approved colour used empty capsule shell | ||||||
| 167 | Rabeprazole Sodium & Domperidone SR Capsules | Each hard gelatin capsule contains: | ||||
| Rabeprazole Sodium | IP | 20 | mg | |||
| (As enteric coated Pellets) | ||||||
| Domperidone | IP | 30 | mg | |||
| (As Sustained release Pellets) | ||||||
| Colour: Approved colour used empty capsule shell | ||||||
| 168 | Rabeprazole Sodium & Levosulphride Capsules | Each hard gelatin capsule contains: | ||||
| Rabeprazole Sodium | IP | 20 | mg | |||
| (As enteric coated Pellets) | ||||||
| Levosulphride | 75 | mg | ||||
| (As Sustained release Pellets) | ||||||
| Colour: Approved colour used empty capsule shell | ||||||
| 169 | Rabeprazole Sodium & Itopride Capsules | Each hard gelatin capsule contains: | ||||
| Rabeprazole Sodium | IP | 20 | mg | |||
| (As enteric coated Pellets) | ||||||
| Itopride | 150 | mg | ||||
| (As Sustained release Pellets) | ||||||
| Colour: Approved colour used empty capsule shell | ||||||
| 170 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
| Itraconazole Pellets Eq. to Itraconazole | 200 | mg | ||||
| Colour: Approved colour used empty capsule shell | ||||||
| 171 | Omeprazole & Domperidone Capsules | Each hard gelatin capsule contains: | ||||
| Omeprazole | IP | 20 | mg | |||
| (As enteric coated Pellets) | ||||||
| Domperidone | IP | 10 | mg | |||
| (As Pellets) | ||||||
| Colour: Approved colour used empty capsule shell | ||||||
| 172 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
| Itraconazole Pellets Eq. to Itraconazole | 100 | mg | ||||
| Colour: Approved colour used empty capsule shell | ||||||
| 173 | Esomeprazole Capsules | Each hard gelatin capsule contains: | ||||
| Esomeprazole Magnesium | IP | |||||
| Eq. to Esomeprazole | 40 | mg | ||||
| (As enteric coated Pellets) | ||||||
| Colour: Approved colour used empty capsule shell | ||||||
| 174 | Amoxycillin Trihydrate Capsules IP | Each hard gelatin capsule contains: | ||||
| Amoxycillin Trihydrate | IP | |||||
| eq. to Amoxycillin | 250 | mg | ||||
| January 1, 1970 | Excipients | q.s. | ||||
| Approved colour used in empty capsule shells | ||||||
| 175 | Amoxycillin Trihydrate Capsules IP | Each hard gelatin capsule contains: | ||||
| Amoxycilline Trihydrate | IP | |||||
| January 1, 1970 | eq. to Amoxycilline | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used in empty capsule shells | ||||||
| 176 | Amoxycillin & Dicloxacillin Sodium Capsules | Each hard gelatin capsule contains: | ||||
| Amoxycillin Trihydrate | IP | |||||
| eq. to Amoxycillin | 250 | mg | ||||
| January 1, 1970 | Dicloxacillin Sodium | IP | ||||
| eq. to Dicloxacillin | 250 | mg | ||||
| Excipients | q.s. | |||||
| Approved colour used in empty capsule shells | ||||||
| 177 | Ampicillin Trihydrate Capsules IP | Each hard gelatin capsule contains: | ||||
| Ampicillin Trihydrate | IP | |||||
| January 1, 1970 | eq. to Ampicillin | 250 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used in empty capsule shells | ||||||
| 178 | Ampicillin Trihydrate Capsules IP | Each hard gelatin capsule contains: | ||||
| Ampicillin Trihydrate | IP | |||||
| eq. to Ampicillin | 500 | mg | ||||
| January 1, 1970 | Excipients | q.s. | ||||
| Approved colour used in empty capsule shells | ||||||
| 179 | Ampicillin & Dicloxacillin Sodium | Each hard gelatin capsule contains: | ||||
| Capsules | Ampicillin Trihydrate | IP | ||||
| eq. to Ampicillin | 250 | mg | ||||
| Dicloxacillin Sodium | IP | |||||
| January 1, 1970 | eq. to Dicloxacillin | 250 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used in empty capsule shells | ||||||
| 180 | Cephalexin Capsules IP | Each hard gelatin capsule contains: | ||||
| Cephalexin Monohydrate | IP | |||||
| January 1, 1970 | eq. to Anhydrous Cephalexin | 500 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used in empty capsule shells | ||||||
| 181 | Cephalexin Capsules IP | Each hard gelatin capsule contains: | ||||
| Cephalexin Monohydrate | IP | |||||
| January 1, 1970 | eq. to Anhydrous Cephalexin | 250 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used in empty capsule shells | ||||||
| 182 | Pregabalin & Methylcobalamin Capsules | Each hard gelatin capsule contains: | ||||
| Pregabalin | IP | 75 | mg | |||
| Methylcobalamin | USP | 750 | mcg | |||
| Excipients | q.s. | |||||
| Approved colour used in empty capsule shells | ||||||
| 183 | Gabapentin & Methylcobalamin Capsules | Each hard gelatin capsule contains: | ||||
| Gabapentin | IP | 300 | mg | |||
| Methylcobalamin | USP | 500 | mcg | |||
| Excipients | q.s. | |||||
| Approved colour used in empty capsule shells | ||||||
| 184 | Amoxycillin For Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
| January 1, 1970 | Amoxycillin Trihydrate | IP | ||||
| January 1, 1970 | eq. to Amoxycillin | 125 | mg | |||
| Excipients | q.s. | |||||
| Colour: Sunset Yellow FCF & Tartrazine | ||||||
| 185 | Amoxycillin For Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
| January 1, 1970 | Amoxycillin Trihydrate | IP | ||||
| January 1, 1970 | eq. to Amoxycillin | 250 | mg | |||
| Excipients | q.s. | |||||
| Colour: Sunset Yellow FCF & Tartrazine | ||||||
| 186 | Cefpodoxime Proxetil Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
| Cefpodoxime Proxetil | IP | |||||
| January 1, 1970 | eq. to Cefpodoxime | 50 | mg | |||
| Excipients | q.s. | |||||
| Colour: Erythrosine | ||||||
| January 1, 1970 | ||||||
| 187 | Cefpodoxime Proxetil Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
| Cefpodoxime Proxetil | IP | |||||
| January 1, 1970 | eq. to Cefpodoxime | 100 | mg | |||
| Excipients | q.s. | |||||
| January 1, 1970 | Colour: Erythrosine | |||||
| 188 | Cefixime Oral Suspension IP | Each5 ml reconstituted suspension contains: | ||||
| Cefixime Trihydrate | IP | |||||
| January 1, 1970 | eq. to Cefixime (Anhydrous) | 50 | mg | |||
| January 1, 1970 | Excipients | q.s. | ||||
| January 1, 1970 | Colour: Quinoline Yellow | |||||
| January 1, 1970 | ||||||
| 189 | Cefixime Oral Suspension IP | Each5 ml reconstituted suspension contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Cefixime (Anhydrous) | 50 | mg | ||||
| Excipients | q.s. | |||||
| Colour: Sunset Yellow | ||||||
| 190 | Cefixime Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Anhydrous Cefixime | 100 | mg | ||||
| Excipients | q.s. | |||||
| Colour: Quinoline Yellow | ||||||
| 191 | Cefuroxime Axetil for Oral Suspension USP | Each 5 ml of reconstituted suspension contains: | ||||
| Cefuroxime Axetil | IP | |||||
| eq. to Cefuroxime | 125 | mg | ||||
| Excipients | q.s. | |||||
| Colour: Quinoline Yellow | ||||||
| 192 | Aceclofenac, Linseed Oil, Methyl | Composition: | ||||
| Salicylate, Capsacin & Menthol Gel | Aceclofenac | IP | 0.015 | w/w | ||
| Linseed Oil | BP | 0.03 | w/w | |||
| Methyl Salicylate | IP | 0.1 | w/w | |||
| Capsacin | BP | 0.00025 | w/w | |||
| (eq. to pure capsaicin not less than 0.01375%w/w) | ||||||
| Menthol | IP | 0.05 | w/w | |||
| Benzyl Alcohol | IP | 0.01 | w/w | |||
| (As Preservative) | ||||||
| In a gel Base | ||||||
| 193 | Clindamycin Phosphate Gel USP | Composition: | ||||
| Clindamycin Phosphate | IP | |||||
| eq to Clindamycin | 0.01 | w/w | ||||
| Gel Base | q.s. | |||||
| 194 | Clotrimazole Cream IP | Composition: | ||||
| Clotrimazole | IP | 0.01 | w/w | |||
| Cream Base | q.s. | |||||
| 195 | Diclofenac Diethylamine, Linseed | Composition: | ||||
| Oil, Methyl Salicylate, Capsacin & | Diclofenac Diethylamine | BP | 0.0116 | w/w | ||
| Menthol Gel | eq. to Diclofenac Sodium | 0.01 | w/w | |||
| Linseed Oil | BP | 0.03 | w/w | |||
| Methyl Salicylate | IP | 0.1 | w/w | |||
| January 1, 1970 | Capsacin | IP | 0.0001 | w/w | ||
| Menthol | IP | 0.05 | w/w | |||
| Cream Base | q.s. | |||||
| 196 | Diclofenac Diethylamine, Linseed | Composition: | ||||
| Oil, Methyl Salicylate & Menthol | Diclofenac Diethylamine | BP | 0.0116 | w/w | ||
| Gel | eq. to Diclofenac Sodium | 0.01 | w/w | |||
| Linseed Oil | BP | 0.03 | w/w | |||
| Methyl Salicylate | IP | 0.1 | w/w | |||
| Menthol | IP | 0.05 | w/w | |||
| Benzyl Alcohol | IP | 0.01 | w/w | |||
| (As Preservative) | ||||||
| Gel Base | ||||||
| 197 | Diclofenac Diethylamine, Linseed | Composition: | ||||
| Oil, Methyl Salicylate & Menthol | Diclofenac Diethylamine | BP | 0.0116 | w/w | ||
| Gel | eq. to Diclofenac Sodium | 0.01 | w/w | |||
| Linseed Oil | BP | 0.03 | w/w | |||
| Methyl Salicylate | IP | 0.1 | w/w | |||
| Menthol | IP | 0.005 | w/w | |||
| Benzyl Alcohol | IP | 0.01 | w/w | |||
| (As Preservative) | ||||||
| Gel Base | ||||||
| 198 | Hydroxquinone, Tretinoin | Composition: | ||||
| Hydrocortisone Cream | Hydroxquinone | USP | 0.02 | w/w | ||
| Tretinoin | USP | 0.0005 | w/w | |||
| Hydrocortisone | IP | 0.01 | w/w | |||
| Cream Base | ||||||
| 199 | Miconazole Nitrate, Salicylic Acid, | Composition: | ||||
| Sublimed Sulpher, Menthol & | Miconazole Nitrate | IP | 0.02 | w/w | ||
| Camphor | Salicylic Acid | IP | 0.1 | w/w | ||
| Sublimed Sulpher | IP | 0.05 | w/w | |||
| January 1, 1970 | Menthol | IP | 0.01 | w/w | ||
| Camphor | IP | 0.01 | w/w | |||
| Ointment Base | q.s. | |||||
| 200 | Mometasone Furoate Cream IP | Composition: | ||||
| Mometasone Furoate | IP | 0.001 | w/w | |||
| Non aqueous Base | q.s. | |||||
| 201 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: | ||||
| Ursodeoxycholic Acid | IP | 300 | mg | |||
| Excipients | q.s. | |||||
| Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
| 202 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each filmcoated tablet contains: | ||||
| Aceclofenac | IP | 100 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Chlorzoxazone | USP | 250 | mg | |||
| Excipients | q.s | |||||
| Colours: Quinoline Yellow | ||||||
| 203 | Clotrimazole Vaginal Tablets | Each uncoated vaginal tablet contains: | ||||
| Clotrimazole | IP | 200 | mg | |||
| Excipients | q.s | |||||
| 204 | Ketoconazole Tablets IP | Each uncoated tablet contains: | ||||
| Ketoconazole | IP | 200 | mg | |||
| Excipients | q.s. | |||||
| 205 | Etophylline & theophyllineTablets | Each uncoated tablet contains: | ||||
| Etophylline | IP (85) | 77 | mg | |||
| Theophylline (Anhydrous) | IP | |||||
| January 1, 1970 | Eq. to Theophylline (Hydrate) | 23 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| 206 | Paracetamol, Phenylepherine HCl & | Each uncoated tablet contains: | ||||
| Levocetirizine HCl Tablets | Paracetamol | IP | 325 | mg | ||
| January 1, 1970 | Phenylepherine Hydrochloride | IP | 5 | mg | ||
| Levocetirizine Hydrochloride | IP | 5 | mg | |||
| Excipients | q.s | |||||
| Colour: Titanium Dioxide IP & Erythrosine | ||||||
| 207 | Levocetirizine HCl & Phenylepherine HCl Tablets | Each film coated tablet contains: | ||||
| Levocetirizine Hydrochloride | IP | 5 | mg | |||
| January 1, 1970 | Phenylepherine HCl | IP | 5 | mg | ||
| Excipients | q.s | |||||
| Colour: Titanium Dioxide IP | ||||||
| 208 | Drotaverine & Mefenamic Acid Tablets | Each filmcoated tablet contains: | ||||
| Drotaverine Hydrochloride | IP | |||||
| Eq. to Drotaverine | 80 | mg | ||||
| Mefenamic Acid | IP | 250 | mg | |||
| Excipients | q.s. | |||||
| Colours: Indigo Caramine | ||||||
| 209 | Sucralfate & Oxetacaine Suspension | Each 10 ml contains: | ||||
| Sucralfate | USP | 1 | gm | |||
| Oxetacaine | BP | 10 | mg | |||
| In a Flavoured palatable base | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 210 | Cyproheptadine & Tricholine | Each 5 ml contains: | ||||
| Citrate Syrup | Cyproheptadine Hydrochloride | IP | 2 | mg | ||
| Tricholine Citrate | 275 | mg | ||||
| Flavoured Syrupy base | q.s | |||||
| Colour: Caramel | ||||||
| 211 | Ambroxol HCl, Guaiphenesin, | Each 5 ml contains: | ||||
| Terbutaline Sulphate & Menthol Syrup | Ambroxol HCl | IP | 15 | mg | ||
| Guaiphenesin | IP | 50 | mg | |||
| January 1, 1970 | Terbutaline Sulphate | IP | 1.25 | mg | ||
| January 1, 1970 | Menthol | IP | 2.5 | mg | ||
| Flavoured Syrupy base | q.s | |||||
| Colour: Tartrazine | ||||||
| 212 | Ambroxol HCl, Guaiphenesin, | Each 5 ml contains: | ||||
| Terbutaline Sulphate & Menthol | Ambroxol HCl | IP | 15 | mg | ||
| Syrup | Guaiphenesin | IP | 50 | mg | ||
| January 1, 1970 | Terbutaline Sulphate | IP | 1.25 | mg | ||
| January 1, 1970 | Menthol | IP | 1 | mg | ||
| Flavoured Syrupy base | q.s | |||||
| Colour: Ponceau 4R | ||||||
| 213 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
| Chlorpheniramine Maleate | Paracetamol | IP | 250 | mg | ||
| Oral Suspension | Phenylephrine HCl | IP | 5 | mg | ||
| Chlorpheniramine Maleate | IP | 2 | mg | |||
| In Flavoured suspension base | ||||||
| Colour: Ponceau 4R | ||||||
| 214 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
| Chlorpheniramine Maleate | Paracetamol | IP | 125 | mg | ||
| Oral Suspension | Phenylephrine HCl | IP | 2.5 | mg | ||
| Chlorpheniramine Maleate | IP | 1 | mg | |||
| In Flavoured suspension base | ||||||
| Colour: Ponceau 4R | ||||||
| 215 | Potassium Citrate & Citric Acid | Each 5 ml contains: | ||||
| Oral Solution | Potassium Citrate Monohydrate | IP | 1100 | mg | ||
| Citric Acid Monohydrate | IP | 334 | mg | |||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Caramel | ||||||
| 216 | Aceclofenac, Paracetamol | Each film coated tablet contains: | ||||
| & Serratiopeptidase tablets | Aceclofenac | IP | 100 | mg | ||
| Paracetamol | IP | 325 | mg | |||
| Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | |||
| January 1, 1970 | Excipients | q.s. | ||||
| Colour: Tartrazine & Titanium Dioxide IP | ||||||
| 217 | Aceclofenac, Paracetamol | Each film coated tablet contains: | ||||
| & Serratiopeptidase tablets | Aceclofenac | IP | 100 | mg | ||
| Paracetamol | IP | 325 | mg | |||
| Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | |||
| January 1, 1970 | Excipients | q.s. | ||||
| Colour: Sunset Yellow & Titanium Dioxide IP | ||||||
| 218 | Cefixime Dispersible Tablets | Each uncoated dispersible tablet contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Anhydrous Cefixime | 50 | mg | ||||
| Excipients | q.s. | |||||
| 219 | Amlodipine & Atenolol Tablets | Each uncoated tablet contains: | ||||
| Amlodipine Besylate | IP | |||||
| eq. to Amlodipine | 5 | mg | ||||
| Atenolol | IP | 50 | mg | |||
| Excipients | q.s. | |||||
| 220 | Ranitidine & Domperidone Tablets | Each film coated tablet contains: | ||||
| Ranitidine Hydrochloride | IP | |||||
| Eq. to Ranitidine | 150 | mg | ||||
| January 1, 1970 | Domperidone | IP | 10 | mg | ||
| Excipients | q.s | |||||
| Colours: Tartrazine & Brilliant Blue | ||||||
| 221 | Diclofenac Potassium & | Each uncoated tablet contains: | ||||
| Paracetamol tablets | Diclofenac Potassium | BP | 50 | mg | ||
| January 1, 1970 | Paracetamol | IP | 325 | mg | ||
| Excipients | q.s. | |||||
| 222 | Tranexamic Acid Tablets IP 500 mg | Each film coated tablet contains: | ||||
| Tranexamic Acid | IP | 500 | mg | |||
| Excipients | q.s. | |||||
| Colours: Quinoline Yellow | ||||||
| 223 | Mefenamic Acid & Tranexamic Acid Tablets | Each film coated tablet contains: | ||||
| Mefenamic Acid | IP | 250 | mg | |||
| Tranexamic Acid | IP | 500 | mg | |||
| Excipients | q.s. | |||||
| Colours: Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
| 224 | Paracetamol & Mefenamic Acid Tablets | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 325 | mg | |||
| January 1, 1970 | Mefenamic Acid | IP | 250 | mg | ||
| Excipients | q.s | |||||
| 225 | Paracetamol Suspension IP | Each 5 ml contains: | ||||
| Paracetamol | IP | 125 | mg | |||
| In Flavoured suspension base | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 226 | Paracetamol Suspension IP | Each 5 ml contains: | ||||
| Paracetamol | IP | 250 | mg | |||
| In Flavoured suspension base | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 227 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
| Chlorpheniramine Maleate | Paracetamol | IP | 125 | mg | ||
| Oral Suspension | Phenylephrine HCl | IP | 5 | mg | ||
| Chlorpheniramine Maleate | IP | 1 | mg | |||
| In Flavoured syrupy base | ||||||
| Colour: Ponceau 4R | ||||||
| 228 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
| Cetirizine Oral Suspension | Paracetamol | IP | 125 | mg | ||
| Phenylephrine HCl | IP | 2.5 | mg | |||
| Cetirizine | IP | 1 | mg | |||
| In Flavoured syrupy base | ||||||
| Colour: Carmoisine | ||||||
| 229 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
| Cetirizine Oral Suspension | Paracetamol | IP | 125 | mg | ||
| Phenylephrine HCl | IP | 5 | mg | |||
| Cetirizine | IP | 2.5 | mg | |||
| In Flavoured syrupy base | ||||||
| Colour: Tartrazine | ||||||
| 230 | Cefpodoxime Proxetil Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
| Cefpodoxime Proxetil | IP | |||||
| January 1, 1970 | eq. to Cefpodoxime | 50 | mg | |||
| Excipients | q.s. | |||||
| Colour: Sunset Yellow | ||||||
| 231 | Chloramphenicol Capsules IP | Each hard gelatin capsule contains: | ||||
| Chloramphenicol | IP | 250 | mg | |||
| January 1, 1970 | Excipients | q.s. | ||||
| Approved colour used in empty capsule shells | ||||||
| 232 | Chloramphenicol Capsules IP | Each hard gelatin capsule contains: | ||||
| Chloramphenicol | IP | 500 | mg | |||
| January 1, 1970 | Excipients | q.s. | ||||
| Approved colour used in empty capsule shells | ||||||
| 233 | Lactulose Solution USP | Each 5 ml contains: | ||||
| Lactulose | ||||||
| (As Lactulose Concentrated) | USP | 3.35 | gm | |||
| In a palatable base | q.s | |||||
| 234 | Methylcobalamin,Alpha Lipoic Acid, Folic Acid & Pyridoxine Hydrochloride Capsules | Each hard gelatin capsule contains: | ||||
| Methylcobalamin | USP | 1500 | mcg | |||
| ( Sr. no. 603 26.09.2007 ) | Alpha Lipoic Acid | USP | 100 | mg | ||
| Folic Acid | IP | 1.5 | mg | |||
| Pyridoxine Hydrochloride | IP | 3 | mg | |||
| Excipients | q.s. | |||||
| Approved colour used in empty capsule shells | ||||||
| 235 | Oxetacaine, Aluminum Hydroxide & | Each 5 ml contains: | ||||
| Magnesium Hydroxide Suspension | Oxetacaine | BP | 10 | mg | ||
| Aluminum Hydroxide | 0.291 | gm | ||||
| (As Dried Aluminium Hydroxide Gel IP 0.380 gm) | ||||||
| January 1, 1970 | Magnesium Hydroxide | IP | 98 | mg | ||
| Sorbital base | q.s | |||||
| Colour: Erythrosine | ||||||
| 236 | Oxetacaine, Aluminum Hydroxide & | Each 5 ml contains: | ||||
| Magnesium Hydroxide Suspension | Oxetacaine | BP | 10 | mg | ||
| Aluminum Hydroxide | 0.291 | gm | ||||
| (As Dried Aluminium Hydroxide Gel IP 0.380 gm) | ||||||
| January 1, 1970 | Magnesium Hydroxide | IP | 98 | mg | ||
| Sorbital base | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 237 | Nimesulide & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Nimesulide | BP | 100 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| Colour: Sunset Yellow FCF & Tartrazine | ||||||
| 238 | Nimesulide & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Nimesulide | BP | 100 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| Colour: Tartrazine & Fast Green | ||||||
| 239 | Deflazacort Tablets | Each uncoated tablet contains: | ||||
| Deflazacort | 6 | mg | ||||
| Excipients | q.s. | |||||
| 240 | Clotrimazole Vaginal Tablets IP | Each uncoated vaginal tablet contains: | ||||
| Clotrimazole | IP | 100 | mg | |||
| Excipients | q.s | |||||
| 241 | Sildenafil Citrate Tablets IP | Each Film-coated tablet contains: | ||||
| Sildenafil Citrate | IP | |||||
| equivalent to Sildenafil | 100 | mg | ||||
| Excipients | q.s | |||||
| Colours: Indigo carmine Lake & Titanium Dioxide IP | ||||||
| 242 | Sildenafil Citrate Tablets IP | Each Film-coated tablet contains: | ||||
| Sildenafil Citrate | IP | |||||
| equivalent to Sildenafil | 100 | mg | ||||
| Excipients | q.s | |||||
| Colours: Titanium Dioxide IP, Iron Oxide Red, Lake of Indigo carmine & Lake of Ponceau 4R | ||||||
| 243 | Sildenafil Citrate Tablets IP | Each Film-coated tablet contains: | ||||
| Sildenafil Citrate | IP | |||||
| equivalent to Sildenafil | 50 | mg | ||||
| Excipients | q.s | |||||
| Colours: Titanium Dioxide IP, Iron Oxide Red, Lake of Indigo carmine & Lake of Ponceau 4R | ||||||
| 244 | Pyrazinamide Tablets IP | Each uncoated tablet contains: | ||||
| Pyrazinamide | IP | 500 | mg | |||
| Excipients | q.s. | |||||
| 245 | Etamsylate Tablets | Each uncoated tablet contains: | ||||
| January 1, 1970 | Etamsylate | BP | 250 | mg | ||
| Excipients | q.s | |||||
| 246 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
| Itraconazole Pellets Eq. to Itraconazole | BP | 100 | mg | |||
| Colour: Approved colour used empty capsule shell | ||||||
| 247 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
| Itraconazole Pellets Eq. to Itraconazole | BP | 200 | mg | |||
| Colour: Approved colour used empty capsule shell | ||||||
| 248 | Ondensetron Oral Solution IP | Each 5 ml contains: | ||||
| Ondansetron HCl | IP | |||||
| eq. to Ondansetron | 2 | mg | ||||
| Flavoured Syrupy base | q.s | |||||
| Colour: Ponceau 4R | ||||||
| 249 | Diphenhydramine Hydrochloride, | Each 5 ml contains: | ||||
| Ammonium Chloride, Sodium Citrate & | Diphenhydramine Hydrochloride | IP | 14.08 | mg | ||
| Menthol Syrup | Ammonium Chloride | IP | 138 | mg | ||
| Sodium Citrate | IP | 57.03 | mg | |||
| Menthol | IP | 1.14 | mg | |||
| In Flavoured syrupy base | q.s. | |||||
| Colour: Ponceau 4R | ||||||
| 250 | Povidone-Iodine Ointment USP | Composition: | ||||
| Povidone-Iodine | IP | 0.05 | w/w | |||
| (available Iodine 0.5% w/w) | ||||||
| Water Soluble Ointment base | q.s. | |||||
| 251 | Mupirocin Ointment IP | Composition: | ||||
| Mupirocin | IP | 0.02 | w/w | |||
| In a non Greasy base | q.s. | |||||
| 252 | Terbinafine Hydrochloride Cream | Composition: | ||||
| Terbinafine Hydrochloride | BP | 0.01 | w/w | |||
| Benzyl Alcohol | IP | 0.01 | w/w | |||
| (as preservative) | ||||||
| In a cream base | ||||||
| 253 | Clotrimazole Vaginal Gel | Composition: | ||||
| Clotrimazole | IP | 0.02 | w/w | |||
| preservatives: | ||||||
| Benzyl Alcohol | IP | 0.02 | w/w | |||
| Chlorocresol | IP | 0.001 | w/w | |||
| Cream Base | q.s. | |||||
| 254 | Gamma Benzene Hexachloride & Cetrimide Lotion | Composition: | ||||
| Gamma Benzene Hexachloride | IP | 0.01 | w/v | |||
| Cetrimide | IP | 0.001 | w/v | |||
| In an emulsion base | q.s | |||||
| 255 | Gamma Benzene Hexachloride Lotion | Composition: | ||||
| Gamma Benzene Hexachloride | IP | 0.01 | w/v | |||
| In an emulsion base | q.s | |||||
| 256 | Paracetamol, Diclofenac Sodium | Each film coated tablet contains: | ||||
| & Serratiopeptidase tablets | Paracetamol | IP | 325 | mg | ||
| Diclofenac Sodium | IP | 50 | mg | |||
| January 1, 1970 | Serratiopeptidase (30,000 units of Serratiopeptidase as enteric coated granules) | IP | 15 | mg | ||
| Excipients | q.s. | |||||
| Colour: Sunset Yellow & Titanium Dioxide IP | ||||||
| 257 | Paracetamol, Diclofenac Sodium | Each film coated tablet contains: | ||||
| & Serratiopeptidase tablets | Paracetamol | IP | 325 | mg | ||
| Diclofenac Sodium | IP | 50 | mg | |||
| January 1, 1970 | Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | ||
| Excipients | q.s. | |||||
| Colour: Sunset Yellow & Titanium Dioxide IP | ||||||
| 258 | Clobetasol Propionate Cream IP | Composition: | ||||
| Clobetasol Propionate | IP | 0.0005 | w/w | |||
| IP-2014 Page no.1424 | Chlorocresol | IP | 0.001 | w/w | ||
| (as preservative) | ||||||
| In a non-greasy base | q.s. | |||||
| 259 | Clobetasol Propionate & | Composition: | ||||
| Miconazole Nitrate Cream | Clobetasol Propionate | IP | 0.0005 | w/w | ||
| Miconazole Nitrate | IP | 0.02 | w/w | |||
| Cream Base | q.s. | |||||
| 260 | Clobetasol Propionate & | Composition: | ||||
| Neomycin Sulphate Cream | Clobetasol Propionate | IP | 0.0005 | w/w | ||
| Neomycin Sulphate | IP | |||||
| eq. to Neomycin | 0.005 | w/w | ||||
| Cream Base | q.s. | |||||
| 261 | Beclomethasone Dipropionate & | Composition: | ||||
| Clotrimazole Cream | Beclomethasone Dipropionate | IP | 0.00025 | w/w | ||
| Clotrimazole | IP | 0.01 | w/w | |||
| Cream base | q.s. | |||||
| 262 | Mometasone Furoate Cream IP | Composition: | ||||
| IP-2014 Page no.2245 | Mometasone Furoate | IP | 0.001 | w/w | ||
| In Cream base | q.s. | |||||
| 263 | Mometasone Furoate & Nadifloxacin | Composition: | ||||
| Cream | Mometasone Furoate | IP | 0.001 | w/w | ||
| 565 Dated 17.08.2006 | Nadifloxacin | 0.01 | w/w | |||
| In Cream base | q.s. | |||||
| 264 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
| Chlorpheniramine Maleate | Paracetamol | IP | 250 | mg | ||
| Oral Suspension | Phenylephrine HCl | IP | 5 | mg | ||
| Chlorpheniramine Maleate | IP | 1 | mg | |||
| In Flavoured suspension base | q.s. | |||||
| Colour: Ponceau 4R | ||||||
| 265 | Paracetamol, Phenylephrine Hydrochloride | Each ml contains: | ||||
| & Chlorpheniramine Maleate Drops | Paracetamol | IP | 125 | mg | ||
| Phenylephrine HCl | IP | 2.5 | mg | |||
| Chlorpheniramine Maleate | IP | 1 | mg | |||
| In Flavoured syrup base | q.s. | |||||
| Colour: Ponceau 4R | ||||||
| 266 | Paracetamol Oral Suspension IP | Each ml contains: | ||||
| Paracetamol | IP | 100 | mg | |||
| In Flavoured syrup base | q.s. | |||||
| Colour: Ponceau 4R | ||||||
| 267 | Aceclofenac & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Aceclofenac | IP | 100 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| January 1, 1970 | Excipients | q.s | ||||
| Colours: Carmoisine & Tartrazine | ||||||
| 268 | Carbonyl Iron, Zinc Sulphate & | Each hard gelatin capsule contains: | ||||
| Folic Acid Capsule | Carbonyl Iron | |||||
| eq. to Elemental Iron | 50 | mg | ||||
| Zinc Sulphate Monohydrate | IP | 61.8 | mg | |||
| (eq. to Elemental Zinc 22.5mg) | ||||||
| Folic Acid | IP | 0.5 | mg | |||
| Approved colour used in empty capsule shells | ||||||
| 269 | Doxylamine Succinate & Pyridoxine Hydrochloride | Each enteric coated tablet contains: | ||||
| Gastro-Resistant Tablets | Doxylamine Succinate | USP | 10 | mg | ||
| Pyridoxine Hydrochloride | IP | 10 | mg | |||
| Excipients | q.s. | |||||
| Colour: Ponceau 4R & Titanium Dioxide IP | ||||||
| 270 | Luliconazole Cream 1.0% w/w | Composition: | ||||
| Luliconazole | 0.01 | w/w | ||||
| In Cream base | q.s. | |||||
| 271 | Diphenhydramine Hydrochloride, | Each 5 ml contains: | ||||
| Ammonium Chloride & Sodium Citrate | Diphenhydramine Hydrochloride | IP | 14.08 | mg | ||
| Syrup | Ammonium Chloride | IP | 138 | mg | ||
| Sodium Citrate | IP | 57.03 | mg | |||
| In Mantholated syrupy base | q.s. | |||||
| Colour: Cramoisine, Sunset Yellow FCF, Erythrosine & Caramel | ||||||
| 272 | Mefenamic Acid Suspension | Each 5 ml contains: | ||||
| Mefenamic Acid | IP | 100 | mg | |||
| In Flavoured syrup base | q.s. | |||||
| Colour: Sunset Yellow FCF | ||||||
| 273 | Levocetirizine Dihydrochloride Syrup | Each 5 ml contains: | ||||
| Levocetirizine Dihydrochloride | IP | 2.5 | mg | |||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Quinoline Yellow WS | ||||||
| 274 | Cetirizine Syrup IP | Each 5 ml contains: | ||||
| Cetirizine Hydrochloride | IP | 5 | mg | |||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 275 | Fexofenadine Hydrochloride Oral Suspension | Each 5 ml contains: | ||||
| Fexofenadine Hydrochloride | IP | 30 | mg | |||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 276 | Fexofenadine Hydrochloride & Montelukast | Each 5 ml contains: | ||||
| Sodium Suspension | Fexofenadine Hydrochloride | IP | 60 | mg | ||
| Montelukast Sodium | IP | |||||
| eq. to Montelukast | 2 | mg | ||||
| In a Flavoured Syrupy base | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 277 | Ketoconazole Tablets IP | Each uncoated tablet contains: | ||||
| Ketoconazole | IP | 200 | mg | |||
| Excipients | q.s. | |||||
| Colour: Sunset Yellow FCF | ||||||
| 278 | Fluconazole & Ivermectin Tablets | Each uncoated tablet contains: | ||||
| Fluconazole | IP | 150 | mg | |||
| Ivermectin | IP | 6 | mg | |||
| Excipients | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 279 | Itraconazole Gel | Composition: | ||||
| Itraconazole | BP | 0.01 | w/w | |||
| In a Gel base | qs | |||||
| 280 | Luliconazole Dusting Powder | Composition: | ||||
| Luliconazole | 0.01 | w/w | ||||
| Talcum I.P. Base | q.s. | |||||
| 281 | Itraconazole Dusting Powder | Composition: | ||||
| Itraconazole | BP | 0.01 | w/w | |||
| Talcum I.P. Base | q.s. | |||||
| 282 | Clotremazole Dusting Powder | Composition: | ||||
| Clotremazole | IP | 0.01 | w/w | |||
| Talcum I.P. Base | q.s. | |||||
| 283 | Miconazole Nitrate Dusting Powder | Composition: | ||||
| Miconazole Nitrate | IP | 0.02 | w/w | |||
| Talcum I.P. Base | q.s. | |||||
| 284 | Artemether & Lumefantrine Dry Syrup | Each 5 ml of reconstituted suspension contains: | ||||
| Artemether | IP | 40 | mg | |||
| January 1, 1970 | Lumefantrine | 240 | mg | |||
| Excipients | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 285 | Azithromycin Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
| Azithromycin | IP | 100 | mg | |||
| Excipients | q.s | |||||
| Colour: Erythrosine | ||||||
| 286 | Azithromycin Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
| Azithromycin | IP | 200 | mg | |||
| Excipients | q.s | |||||
| Colour: Sunset Yellow FCF | ||||||
| 287 | Itraconazole Sustained Release Tablets 400 mg | Each Film Coated Sustained Release tablet contains: | ||||
| Itraconazole | BP | 400 | mg | |||
| Excipients | q.s. | |||||
| Colour: Titanium Dioxide IP | ||||||
| 288 | Ketorolac Tromethamine Tablets IP | Each uncoated tablet contains: | ||||
| Ketorolac Tromethamine | IP | 10 | mg | |||
| Excipients | q.s. | |||||
| 289 | Tamsulotion Hydrochloride Modified Release | Each hard gelatin capsule contains: | ||||
| Capsule | Tamsulotion Hydrochloride | IP | 400 | mcg | ||
| (As Modified Release Pellets) | ||||||
| Excipients | q.s. | |||||
| Approved colour used in empty capsule shells | ||||||
| 290 | Cefpodoxime Proxetil Dispersible | Each uncoated dispersible tablet contains: | ||||
| Tablets | Cefpodoxime Proxetil | IP | ||||
| eq. to Cefpodoxime | 50 | mg | ||||
| Excipients | q.s. | |||||
| 291 | Metformin Hydrochloride Tablets IP | Each uncoated tablet contains: | ||||
| Metformin Hydrochloride | IP | 500 | mg | |||
| Excipients | q.s | |||||
| 292 | Calcium with vitamin D3 Tablets IP | Each film coated tablet contains: | ||||
| 1.25 g Calcium carbonate from an organic | ||||||
| source (Oyster Shell) | ||||||
| Eq. to elemental calcium | 500 | mg | ||||
| Vitamin D3 | IP | 250 | IU | |||
| Colour: Brilliant Blue FCF & Titanium Dioxide IP | ||||||
| 293 | Diclofenac Sodium & Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
| Diclofenac Sodium | IP | 50 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| 294 | Diclofenac Sodium & Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
| Diclofenac Sodium | IP | 50 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| Colour: Quinoline Yellow | ||||||
| 295 | Diclofenac Sodium & Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
| Diclofenac Sodium | IP | 50 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| Colours: Tartrazine & Fast Green | ||||||
| 296 | Ofloxacin & Ornidazole Tablets IP | Each film coated tablet contains: | ||||
| Ofloxacin | IP | 200 | mg | |||
| Ornidazole | IP | 500 | mg | |||
| Excipients | q.s | |||||
| Colours: Sunset Yellow FCF, Tartrazine & Titanium Dioxide IP | ||||||
| 297 | Dicyclomine Hydrochloride & Mefenamic Acid Tablets IP | Each uncoated tablet contains: | ||||
| Dicyclomine Hydrochloride | IP | 10 | mg | |||
| Mefenamic Acid | IP | 250 | mg | |||
| Excipients | q.s | |||||
| Colour: Tartrazine | ||||||
| 298 | Ibuprofen & Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
| Ibuprofen | IP | 400 | mg | |||
| Paracetamol | IP | 325 | mg | |||
| Excipients | q.s | |||||
| 299 | Montelukast Sodium & Levocetirizine HCl Tablets | Each film coated tablet contains: | ||||
| IP | Montelukast Sodium | IP | ||||
| Eq. to Montelukast | 10 | mg | ||||
| January 1, 1970 | Levocetirizine Di Hydrochloride | IP | 5 | mg | ||
| Excipients | q.s | |||||
| Colours: Quinoline Yellow & Titanium Dioxide IP | ||||||
| 300 | Terbinafine Hydrochloride Tablets IP | Each uncoated tablet contains: | ||||
| Terbinafine Hydrochloride | IP | |||||
| eq. to Terbinafine | 250 | mg | ||||
| Excipients | q.s | |||||
| 301 | Paracetamol & Caffeine Tablets IP | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 325 | mg | |||
| January 1, 1970 | Caffeine | IP | 30 | mg | ||
| Excipients | q.s | |||||
| Colour: Red Oxide of Iron | ||||||
| 302 | Cefixime Dispersible Tablets IP | Each uncoated dispersible tablet contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Anhydrous Cefixime | 50 | mg | ||||
| Excipients | q.s. | |||||
| 303 | Cefixime Dispersible Tablets IP | Each uncoated dispersible tablet contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Anhydrous Cefixime | 100 | mg | ||||
| Excipients | q.s. | |||||
| 304 | Cefixime Dispersible Tablets IP | Each uncoated dispersible tablet contains: | ||||
| Cefixime Trihydrate | IP | |||||
| eq. to Anhydrous Cefixime | 200 | mg | ||||
| Excipients | q.s. | |||||
| 305 | Pantoprazole Gesto-resistant & Domperidone Prolonged-release Capsules IP | Each hard gelatin capsule contains: | ||||
| Pantoparazole Sodium Sesquihydrate | IP | |||||
| Eq. to Pantoprazole | 40 | mg | ||||
| (As enteric coated Pellets) | ||||||
| Domperidone | IP | 30 | mg | |||
| (As Sustained release Pellets) | ||||||
| Colour: Approved colour used empty capsule shell | ||||||
| 306 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
| Itraconazole Pellets | ||||||
| Eq. to Itraconazole | BP | 100 | mg | |||
| Excipients | qs | |||||
| Colour: Titanium Dioxide IP, Brilliant Bule FCF & Tartrazine colours used in empty capsule shells. | ||||||
| 307 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
| Itraconazole Pellets | ||||||
| Eq. to Itraconazole | BP | 200 | mg | |||
| Excipients | qs | |||||
| Colour: Titanium Dioxide IP, Sunset Yellow FCF, Ponceau-4R & Carmoisine colours used in empty capsule shells. | ||||||
| 308 | Thiocolchicoside & Aceclofenac Tablets | Each film coated contains: | ||||
| Thiocolchicoside | IP | 4 | mg | |||
| Aceclofenac | IP | 100 | mg | |||
| Excipients | qs | |||||
| Colours: Quinoline yellow & Titanium Dioxide IP | ||||||
| 309 | Etoricoxib & Thiocolchicoside Tablets | Each film coated contains: | ||||
| Etoricoxib | IP | 60 | mg | |||
| Thiocolchicoside | IP | 4 | mg | |||
| Excipients | qs | |||||
| Colours: Tartrazine | ||||||
| 310 | Arterolane Maleate & Piperaquine | Each film coated contains: | ||||
| Phosphate Tablets | Arterolane Maleate | IP | ||||
| eq. to Arterolane | 150 | mg | ||||
| Piperaquine Phosphate | 750 | mg | ||||
| Excipients | qs | |||||
| Colours: Yellow oxide of iron, Red oxide of iron & Titanium Dioxide IP | ||||||
| 311 | Losartan Potassium Tablets IP | Each uncoated Tablet contains: | ||||
| Losartan Potassium | IP | 25 | mg | |||
| Excipients | qs | |||||
| Colour: Titanium Dioxide I.P. | ||||||
| 312 | Losartan Potassium Tablets IP | Each uncoated Tablet contains: | ||||
| Losartan Potassium | IP | 50 | mg | |||
| Excipients | qs | |||||
| Colour: Titanium Dioxide I.P. | ||||||
| 313 | Losartan Potassium Tablets IP | Each Film coated Tablet contains: | ||||
| Losartan Potassium | IP | 25 | mg | |||
| Excipients | qs | |||||
| Colour: Approved Colour Used | ||||||
| 314 | Losartan Potassium Tablets IP | Each film coated Tablet contains: | ||||
| Losartan Potassium | IP | 50 | mg | |||
| Excipients | qs | |||||
| Colour: Approved Colour Used | ||||||
| 315 | Terbinafine Hydrochloride Tablets IP | Each uncoated tablet contains: | ||||
| Terbinafine Hydrochloride | IP | |||||
| eq. to Terbinafine | 500 | mg | ||||
| Excipients | q.s | |||||
| 316 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: | ||||
| Page No. 3466 (IP2018) | Ursodeoxycholic Acid | IP | 300 | mg | ||
| Excipients | q.s. | |||||
| Colour: Titanium Dioxide IP | ||||||
| 317 | Atorvastatin & Aspirin Capsules | Each hard gelatin capsule contains: | ||||
| Atorvastatin Calcium | IP | |||||
| S. No.-771 DCGI 18/01/2008 | Eq. to Atorvastatin | 10 | mg | |||
| (as immediate release pellets) | ||||||
| Aspirin | IP | 75 | mg | |||
| (As enteric coated pellets) | ||||||
| Excipients | qs | |||||
| Approved colours used in empty capsule shells and pellets. | ||||||
| 318 | Atorvastatin & Aspirin Capsules | Each hard gelatin capsule contains: | ||||
| Atorvastatin Calcium | IP | |||||
| S. No.-771 DCGI 18/01/2008 | Eq. to Atorvastatin | 10 | mg | |||
| (as immediate release pellets) | ||||||
| Aspirin | IP | 150 | mg | |||
| (As enteric coated pellets) | ||||||
| Excipients | qs | |||||
| Approved colours used in empty capsule shells and pellets. | ||||||
| 319 | Amlodipine & Atorvastatin Tablets | Each film coated tablet contains: | ||||
| Amlodipine Besylate | IP | |||||
| S. No.- 414 DCGI-11/02/2004 | eq. to Amlodipine | 5 | mg | |||
| Atorvastatin Calcium | IP | |||||
| Eq. to Atorvastatin | 10 | mg | ||||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 320 | Amlodipine & Atorvastatin Tablets | Each uncoated tablet contains: | ||||
| Amlodipine Besylate | IP | |||||
| S. No.- 431 DCGI-20/10/2004 | eq. to Amlodipine | 5 | mg | |||
| Atorvastatin Calcium | IP | |||||
| Eq. to Atorvastatin | 20 | mg | ||||
| Excipients | q.s. | |||||
| 321 | Amlodipine & Atorvastatin Tablets | Each uncoated tablet contains: | ||||
| Amlodipine Besylate | IP | |||||
| S. No.- 431 DCGI-20/10/2004 | eq. to Amlodipine | 5 | mg | |||
| Atorvastatin Calcium | IP | |||||
| Eq. to Atorvastatin | 40 | mg | ||||
| Excipients | q.s. | |||||
| 322 | Amlodipine & Atorvastatin Tablets | Each uncoated tablet contains: | 28.25 | |||
| Amlodipine Besylate | IP | |||||
| S. No.- 431 DCGI-20/10/2004 | eq. to Amlodipine | 10 | mg | |||
| Atorvastatin Calcium | IP | |||||
| Eq. to Atorvastatin | 10 | mg | ||||
| Excipients | q.s. | |||||
| 323 | Amlodipine & Atorvastatin Tablets | Each uncoated tablet contains: | 2.3958333333333 | |||
| Amlodipine Besylate | IP | |||||
| S. No.- 431 DCGI-20/10/2004 | eq. to Amlodipine | 10 | mg | |||
| Atorvastatin Calcium | IP | |||||
| Eq. to Atorvastatin | 20 | mg | ||||
| Excipients | q.s. | |||||
| 324 | Amlodipine & Atorvastatin Tablets | Each uncoated tablet contains: | 24.001736111111 | |||
| Amlodipine Besylate | IP | |||||
| S. No.- 431 DCGI-20/10/2004 | eq. to Amlodipine | 10 | mg | |||
| Atorvastatin Calcium | IP | |||||
| Eq. to Atorvastatin | 40 | mg | ||||
| Excipients | q.s. | |||||
| 325 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 434 DCGI-08/11/2004 | Eq. to Atorvastatin | 10 | mg | |||
| Ezetimibe | IP | 10 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 326 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 434 DCGI-08/11/2004 | Eq. to Atorvastatin | 20 | mg | |||
| Ezetimibe | IP | 10 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 327 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 663 DCGI-30/07/2007 | Eq. to Atorvastatin | 40 | mg | |||
| Ezetimibe | IP | 10 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 328 | Atorvastatin & Metoprolol Succinate (ER) | Each uncoated bilayer tablet contains: | 24.001736111111 | |||
| Tablets | Atorvastatin Calcium | IP | ||||
| S. No.- 791 DCGI-28/01/2008 | Eq. to Atorvastatin | 10 | mg | |||
| Metoprolol Succinate | IP | 47.5 | mg | |||
| eq. to Metoprolol Tartrate | 50 | mg | ||||
| (As Extended Release Form) | ||||||
| Excipients | q.s. | |||||
| Colours: Approved Colour used | ||||||
| 329 | Atorvastatin & Metoprolol Succinate (ER) | Each uncoated bilayer tablet contains: | 24.001736111111 | |||
| Tablets | Atorvastatin Calcium | IP | ||||
| S. No.- 791 DCGI-28/01/2008 | Eq. to Atorvastatin | 10 | mg | |||
| Metoprolol Succinate | IP | 23.75 | mg | |||
| eq. to Metoprolol Tartrate | 25 | mg | ||||
| (As Extended Release Form) | ||||||
| Excipients | q.s. | |||||
| Colours: Approved Colour used | ||||||
| 330 | Atorvastatin & Telmisartan Tablets | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 747 DCGI-22/05/2008 | Eq. to Atorvastatin | 10 | mg | |||
| Telmisartan | IP | 40 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 331 | Atorvastatin & Metformin HCl (SR) | Each uncoated tablet contains: | 24.001736111111 | |||
| Tablets | Atorvastatin Calcium | IP | ||||
| Eq. to Atorvastatin | 10 | mg | ||||
| S. No.- 878 DCGI-04/12/2008 | Metformin Hydrochloride | IP | 500 | mg | ||
| (As Sustained Release Form) | ||||||
| Excipients | q.s. | |||||
| Colours: Approved Colour used | ||||||
| 332 | Atorvastatin, Glimepiride & Metformin | Each uncoated tablet contains: | 24.001736111111 | |||
| HCl (SR) Tablets | Atorvastatin Calcium | IP | ||||
| Eq. to Atorvastatin | 10 | mg | ||||
| S. No.- 957 DCGI-17/12/2009 | Glimepiride | IP | 1 | mg | ||
| Metformin Hydrochloride | IP | 500 | mg | |||
| (As Extended Release Form) | ||||||
| Excipients | q.s. | |||||
| Colours: Approved Colour used | ||||||
| 333 | Atorvastatin, Glimepiride & Metformin | Each uncoated tablet contains: | 24.001736111111 | |||
| HCl (SR) Tablets | Atorvastatin Calcium | IP | ||||
| Eq. to Atorvastatin | 10 | mg | ||||
| S. No.- 957 DCGI-17/12/2009 | Glimepiride | IP | 2 | mg | ||
| Metformin Hydrochloride | IP | 500 | mg | |||
| (As Sustained Release Form) | ||||||
| Excipients | q.s. | |||||
| Colours: Approved Colour used | ||||||
| 334 | Atorvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 776 DCGI-25/01/2008 | Eq. to Atorvastatin | 10 | mg | |||
| Fenofibrate | IP | 80 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 335 | Atorvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 438 DCGI-24/12/2004 | Eq. to Atorvastatin | 10 | mg | |||
| Fenofibrate | IP | 160 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 336 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
| Tablets | Atorvastatin Calcium | IP | ||||
| Eq. to Atorvastatin | 5 | mg | ||||
| S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 20 | mg | ||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 337 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
| Tablets | Atorvastatin Calcium | IP | ||||
| Eq. to Atorvastatin | 10 | mg | ||||
| S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 20 | mg | ||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 338 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
| Tablets | Atorvastatin Calcium | IP | ||||
| Eq. to Atorvastatin | 20 | mg | ||||
| S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 20 | mg | ||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 339 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
| Tablets | Atorvastatin Calcium | IP | ||||
| Eq. to Atorvastatin | 5 | mg | ||||
| S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 40 | mg | ||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 340 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
| Tablets | Atorvastatin Calcium | IP | ||||
| Eq. to Atorvastatin | 10 | mg | ||||
| S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 40 | mg | ||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 341 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
| Tablets | Atorvastatin Calcium | IP | ||||
| Eq. to Atorvastatin | 20 | mg | ||||
| S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 40 | mg | ||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 342 | Atorvastatin & Ramipril Tablets | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 680 DCGI-15/10/2007 | Eq. to Atorvastatin | 10 | mg | |||
| Ramipril | IP | 2.5 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 343 | Atorvastatin & Ramipril Tablets | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 680 DCGI-15/10/2007 | Eq. to Atorvastatin | 10 | mg | |||
| Ramipril | IP | 5 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 344 | Atorvastatin & Ramipril Tablets | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 1002 DCGI-17/03/2010 | Eq. to Atorvastatin | 20 | mg | |||
| Ramipril | IP | 2.5 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 345 | Atorvastatin & Ramipril Tablets | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 1002 DCGI-17/03/2010 | Eq. to Atorvastatin | 20 | mg | |||
| Ramipril | IP | 5 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 346 | Atorvastatin Tablets IP | Each film coated tablet contains: | -87.994791666667 | |||
| Atorvastatin Calcium | IP | |||||
| Page No.- 1287 IP-2018 | Eq. to Atorvastatin | 20 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 347 | Atorvastatin Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| Page No.- 1287 IP-2018 | Eq. to Atorvastatin | 40 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 348 | Atorvastatin Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| Page No.- 1287 IP-2018 | Eq. to Atorvastatin | 80 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 349 | Rosuvastatin Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
| Rosuvastatin Calcium | IP | |||||
| Page No.- 3142 IP-2018 | Eq. to Rosuvastatin | 40 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 350 | Rosuvastatin Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
| Rosuvastatin Calcium | IP | |||||
| Page No.- 3142 IP-2018 | Eq. to Rosuvastatin | 80 | mg | |||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 351 | Rosuvastatin & Aspirin Capsules | Each hard gelatin capsule contains: | ||||
| Rosuvastatin Calcium | IP | |||||
| Eq. to Rosuvastatin | 10 | mg | ||||
| S. No.- 1101 DCGI-30/03/2011 | (As film coated pellets) | |||||
| Aspirin | IP | 150 | mg | |||
| (As enteric coated pellets) | ||||||
| Excipients | q.s. | |||||
| Approved colours used in empty capsule shells and pellets. | ||||||
| 352 | Aspirin & Clopidogrel Capsules | Each uncoated tablet contains: | 24.001736111111 | |||
| Aspirin | IP | 75 | mg | |||
| (As enteric coated pellets) | ||||||
| S. No.- 365 DCGI-27/11/2002 | Clopidogrel Bisulphate | IP | ||||
| eq. to Clopidogrel | 75 | mg | ||||
| (As immediate release pellets) | ||||||
| Excipients | q.s. | |||||
| Approved colours used in empty capsule shells and pellets. | ||||||
| 353 | Atorvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
| Atorvastatin Calcium | IP | |||||
| S. No.- 487 DCGI-30/10/2007 | Eq. to Atorvastatin | 10 | mg | |||
| Page No.- 1289 IP-2018 | Fenofibrate | IP | 145 | mg | ||
| Excipients | q.s. | |||||
| Colours: Approved Colour used in coating | ||||||
| 354 | Ofloxacin Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
| Ofloxacin | IP | 400 | mg | |||
| Page No.- 2769 IP-2018 | Excipients | q.s. | ||||
| Colour: Titanium Dioxide IP | ||||||
| 355 | Promethazine Hydrochloride Tablets IP | Each uncoated tablet contains: | 24.001736111111 | |||
| Page No.- 3016 IP-2018 | Promethazine Hydrochloride | IP | 25 | mg | ||
| Excipients | q.s. | |||||
| 356 | Gliclazide Tablets IP | Each Uncoated Tablet Contains: | ||||
| Gliclazide | I.P. | 80 mg | ||||
| Excipients | QS | |||||
| 357 | Glimepiride Tablets IP | Each Uncoated Tablet Contains: | ||||
| Glimepiride | I.P. | 1 mg | ||||
| Excipients | QS | |||||
| 358 | Glimepiride Tablets IP | Each Uncoated Tablet Contains: | ||||
| Glimepiride | I.P. | 2 mg | ||||
| Excipients | QS | |||||
| 359 | Voglibose and Metformin HCl (Extended Release) Tablets | Each uncoated Bilayered tablet contains | ||||
| Voglibose | I.P. | 0.3 mg | ||||
| Metformin Hydrochloride | I.P. | 500 mg | ||||
| (As Extended Release) | ||||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 360 | Amlodipine and Clopidogrel Tablets | Each Film coated Tablet contains | ||||
| Amlodipine Besylate | I.P. | |||||
| Eq. To Amlodipine | 5 mg | |||||
| Clopidogrel Bisulphate | I.P. | |||||
| Eq. to Clopidogrel | 75 mg | |||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 361 | Clopidogrel and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
| Aspirin | I.P. | 100 mg | ||||
| As Enteric Coated Pellets | ||||||
| Clopidogrel Bisulphate | I.P. | |||||
| Eq. to Clopidogrel | 75 mg | |||||
| As Pellets | ||||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 362 | Clopidogrel and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
| Aspirin | I.P. | 75 mg | ||||
| As Enteric Coated Pellets | ||||||
| Clopidogrel Bisulphate | I.P. | |||||
| Eq. to Clopidogrel | 150 mg | |||||
| As Pellets | ||||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 363 | Clopidogrel and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
| Aspirin | I.P. | 150 mg | ||||
| As Enteric Coated Pellets | ||||||
| Clopidogrel Bisulphate | I.P. | |||||
| Eq. to Clopidogrel | 300 mg | |||||
| As Pellets | ||||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 364 | Rosuvastatin and Fenofibrate Tablets | Each film coated tablet contains | ||||
| Rosuvastatin Calcium | I.P. | |||||
| Eq. to Rosuvastatin | 5 mg | |||||
| Finofibrate | I.P. | 67 mg | ||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 365 | Rosuvastatin and Fenofibrate Tablets | Each film coated tablet contains | ||||
| Rosuvastatin Calcium | I.P. | |||||
| Eq. to Rosuvastatin | 10 mg | |||||
| Finofibrate | I.P. | 145 mg | ||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 366 | Rosuvastatin and Fenofibrate Tablets | Each film coated tablet contains | ||||
| Rosuvastatin Calcium | I.P. | |||||
| Eq. to Rosuvastatin | 20 mg | |||||
| Finofibrate | I.P. | 160 mg | ||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 367 | Rosuvastatin, and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
| Rosuvastatin Calcium | I.P. | |||||
| Eq. to Rosuvastatin | 5 mg | |||||
| (As Pellets) | ||||||
| Aspirin | I.P. | 75 mg | ||||
| (As Enteric Coated Pellets) | ||||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 368 | Rosuvastatin, and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
| Rosuvastatin Calcium | I.P. | |||||
| Eq. to Rosuvastatin | 10 mg | |||||
| (As Pellets) | ||||||
| Aspirin | I.P. | 150 mg | ||||
| (As Enteric Coated Pellets) | ||||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 369 | Rosuvastatin and Ezetimibe Tablets | Each film coated tablet contains | ||||
| Rosuvastatin Calcium | I.P. | |||||
| Eq. to Rosuvastatin | 5 mg | |||||
| Ezetimibe | 10 mg | |||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 370 | Simvastatin, Ramipril, Atenolol, Hydrochlorthiazide and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
| Simvastatin | B.P. | 20 mg | ||||
| (As Pellets) | ||||||
| Ramipril | I.P. | 5 mg | ||||
| (As Pellets) | ||||||
| Atenolol | I.P. | 50 mg | ||||
| (As Pellets) | ||||||
| Hydrochlorothiazide | I.P. | 12.5 mg | ||||
| (As Pellets) | ||||||
| Aspirin | I.P. | 100 mg | ||||
| (As Enteric Coated Pellets) | ||||||
| Excipients | ||||||
| Approved colour used. | ||||||
| 371 | Amlodipine and Perindopril Tablets | Each film coated tablet contains | ||||
| Amlodipine Besylate | I.P. | |||||
| Eq. to Amlodipine | 5 mg | |||||
| Perindopril Arginine | ||||||
| Eq. to Perindopril | 8 mg | |||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 372 | Amlodipine and Indapamide Tablets | Each film coated tablet contains | ||||
| Amlodipine Besylate | I.P. | |||||
| Eq. to Amlodipine | 10 mg | |||||
| Indapamide | U.S.P. | 1.5 mg | ||||
| (As Sustained Release) | ||||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 373 | Telmisarton, Amlodipine and Hydrochlorothiazide Tablets | Each film coated tablet contains | ||||
| Telmisartan | I.P. | 20 mg | ||||
| Amlodipine Besylate | I.P. | |||||
| Eq. to Amlodipine | 2.5 mg | |||||
| Hydrochlorothiazide | I.P. | 6.25 mg | ||||
| (As Sustained Release) | ||||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 374 | Amlodipine and Hydrochlorothiazide Tablets | Each film coated tablet contains | ||||
| Amlodipine Besylate | I.P. | |||||
| Eq. to Amlodipine | 5 mg | |||||
| Hydrochlorothiazide | I.P. | 25 mg | ||||
| Excipients | QS | |||||
| Approved colour used. | ||||||
| 375 | Pregabalin and Mecobalamin Capsules | Each Hard Gelatin Capsule contains | ||||
| Pregabalin | I.P. | 75 mg | ||||
| Mecobalamin | U.S.P. | 750 mcg | ||||
| Appropriate overages of Mecobalamin added | ||||||
| Excipients | QS | |||||
| Approved colour used in capsules shell | ||||||
| 376 | Pregabalin, Mecobalamin, Pyridoxine, Folic Acid and Benfothiamine Capsules | Each Hard Gelatin Capsule contains | ||||
| Pregabalin | I.P. | 150 mg | ||||
| Mecobalamin | U.S.P. | 75 mcg | ||||
| Pyridoxine Hydrochloride | I.P. | 1.5 mg | ||||
| Folic Acid | I.P. | 0.75 mg | ||||
| Benfothiamine | 7.5 mg | |||||
| Excipients | QS | |||||
| Appropriate overages of Vitamins are added | ||||||
| Approved colour used in capsules shell | ||||||
| 377 | Ambroxol, Guaiphenesin and Levosalbutamol Syrup | Each 5 ml contains | ||||
| Ambroxol Hydrochloride | I.P. | 30 mg | ||||
| Guiphenesin | I.P. | 50 mg | ||||
| Levosalbutamol Sulphate | I.P. | |||||
| Eq. to Levosalbutamol | 1 mg | |||||
| In a mentholated syrupy base | QS | |||||
| Approved colour used. |